KR102121437B1 - Novel ligand compound and transition metal compound comprising the same - Google Patents
Novel ligand compound and transition metal compound comprising the same Download PDFInfo
- Publication number
- KR102121437B1 KR102121437B1 KR1020160107068A KR20160107068A KR102121437B1 KR 102121437 B1 KR102121437 B1 KR 102121437B1 KR 1020160107068 A KR1020160107068 A KR 1020160107068A KR 20160107068 A KR20160107068 A KR 20160107068A KR 102121437 B1 KR102121437 B1 KR 102121437B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- transition metal
- tert
- butyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/28—Titanium compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/38—Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/42—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
- C08F4/44—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
- C08F4/60—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
- C08F4/62—Refractory metals or compounds thereof
- C08F4/64—Titanium, zirconium, hafnium or compounds thereof
- C08F4/64003—Titanium, zirconium, hafnium or compounds thereof the metallic compound containing a multidentate ligand, i.e. a ligand capable of donating two or more pairs of electrons to form a coordinate or ionic bond
- C08F4/64082—Tridentate ligand
- C08F4/6411—Monoanionic ligand
- C08F4/64124—ONO
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
Abstract
본 발명은 신규 리간드 화합물 및 이를 포함하는 전이금속 화합물에 관한 것으로, 본 발명에 따른 신규한 구조의 전이금속 화합물은 올리핀계 중합체를 제조하는데 있어 중합 반응 촉매로 사용될 수 있다. The present invention relates to a novel ligand compound and a transition metal compound containing the same, and the novel structured transition metal compound according to the present invention can be used as a polymerization reaction catalyst in preparing an oliphine-based polymer.
Description
본 발명은 신규한 리간드 화합물 및 상기 리간드 화합물을 포함하는 전이금속 화합물에 관한 것이다.The present invention relates to a novel ligand compound and a transition metal compound comprising the ligand compound.
기존의 폴리올레핀의 상업적 제조 과정에는 티타늄 또는 바나듐 화합물의 지글러-나타 촉매가 널리 사용되어 왔는데, 상기 지글러-나타 촉매는 높은 활성을 갖지만, 다활성점 촉매이기 때문에 생성 고분자의 분자량 분포가 넓으며 공단량체의 조성 분포가 균일하지 않아 원하는 물성 확보에 한계가 있었다.Ziegler-Natta catalysts of titanium or vanadium compounds have been widely used in the commercial production process of conventional polyolefins. Although the Ziegler-Natta catalyst has a high activity, the molecular weight distribution of the resulting polymer is wide and the comonomer is a multi-activation catalyst. There was a limitation in securing the desired physical properties because the composition distribution of was not uniform.
이에 따라, 최근에는 티타늄, 지르코늄, 하프늄 등의 전이 금속과 사이클로펜타디엔 작용기를 포함하는 리간드가 결합된 메탈로센 촉매가 개발되어 널리 사용되고 있다. 메탈로센 화합물은 일반적으로 알루미녹산, 보레인, 보레이트 또는 다른 활성화제를 이용하여 활성화시켜 사용한다. 예를 들어, 사이클로펜타다이에닐기를 포함한 리간드와 두 개의 시그마 클로라이드 리간드를 갖는 메탈로센 화합물은 알루미녹산을 활성화제로 사용한다. 이러한 메탈로센 화합물의 클로라이드기를 다른 리간드(예를 들어, 벤질 또는 트리메틸실릴메틸기(-CH2SiMe3))로 치환하는 경우 촉매 활성도 증가 등의 효과를 나타내는 예가 보고되었다.Accordingly, recently, metallocene catalysts in which ligands including transition metals such as titanium, zirconium, and hafnium and cyclopentadiene functional groups are combined have been developed and widely used. Metallocene compounds are generally activated by using aluminoxane, borane, borate or other activators. For example, a metallocene compound having a ligand including a cyclopentadienyl group and two sigma chloride ligands uses aluminoxane as an activator. In the case of substituting the chloride group of the metallocene compound with another ligand (for example, benzyl or trimethylsilylmethyl group (-CH 2 SiMe 3 )), an example showing an effect such as an increase in catalytic activity has been reported.
Dow 사는 1990년대 초반 [Me2Si(Me4C5)NtBu]TiCl2 (Constrained-Geometry Catalyst, CGC)를 미국특허 제5,064,802호 등에서 개시하였는데, 에틸렌과 알파-올레핀의 공중합 반응에서 CGC가 기존까지 알려진 메탈로센 촉매들에 비해 우수한 측면을 크게 다음과 같이 두 가지로 요약할 수 있다: (1) 높은 중합 온도에서도 높은 활성도를 나타내면서 고분자량의 중합체를 생성하며, (2) 1-헥센 및 1-옥텐과 같은 입체적 장애가 큰 알파-올레핀의 공중합성도 매우 뛰어나다는 점이다. 그 외에도 중합 반응 시, CGC 의 여러 가지 특성들이 점차 알려지면서 이의 유도체를 합성하여 중합 촉매로 사용하고자 하는 노력이 학계 및 산업계에서 활발히 이루어지고 있다.Dow Corporation [Me 2 Si(Me 4 C 5 )N t Bu]TiCl 2 (Constrained-Geometry Catalyst, CGC) was disclosed in U.S. Patent No. 5,064,802, in the early 1990s. The superior aspect compared to the known metallocene catalysts can be broadly summarized as follows: (1) It produces high-molecular weight polymers with high activity even at high polymerization temperatures, and (2) 1-hexene And that the copolymerization of alpha-olefin having a large steric hindrance such as 1-octene is also excellent. In addition, in the polymerization reaction, various properties of CGC are gradually known, and efforts to synthesize derivatives thereof and use them as polymerization catalysts have been actively conducted in academia and industry.
그 중 하나의 접근 방법으로 실리콘 브릿지 대신에 다른 다양한 브릿지 및 질소 치환체가 도입된 금속 화합물의 합성과 이를 이용한 중합이 시도되었다. 최근까지 알려진 대표적인 금속 화합물들은 CGC 구조의 실리콘 브릿지 대신에 포스포러스, 에틸렌 또는 프로필렌, 메틸리덴 및 메틸렌 브릿지가 각각 도입되어 있으나, 에틸렌 중합 또는 에틸렌과 알파올레핀의 공중합에의 적용시에 CGC 대비하여 중합 활성도나 공중합 성능 등의 측면에서 뛰어난 결과들을 나타내지 못하였다.As one of the approaches, synthesis of a metal compound in which various other bridges and nitrogen substituents were introduced instead of a silicon bridge and polymerization using the same were attempted. Representative metal compounds known until recently have introduced phosphorus, ethylene or propylene, methylidene and methylene bridges instead of CGC-structured silicon bridges, but polymerized in comparison to CGC when applied to ethylene polymerization or copolymerization of ethylene and alpha olefins It did not show excellent results in terms of activity or copolymerization performance.
다른 접근 방법으로는 상기 CGC의 아미도 리간드 대신에 옥시도 리간드로 구성된 화합물들 많이 합성되었으며, 이를 이용한 중합도 일부 시도된 바 있다. As another approach, a large number of compounds composed of oxido ligands have been synthesized instead of the amido ligands of CGC, and polymerization using them has been partially attempted.
그러나, 이러한 모든 시도들 중에서 실제로 상업 공장에 적용되고 있는 촉매들은 몇몇에 불과한 수준으로, 보다 향상된 중합 성능을 나타내는 촉매에 대한 요구가 여전히 지속되고 있는 실정이다.However, among all these attempts, catalysts that are actually applied to commercial plants are only a few, and there is still a need for a catalyst that exhibits improved polymerization performance.
본 발명은 높은 촉매활성, 선택도로 올레핀계 중합체를 제조할 수 있는 신규한 리간드 화합물 및 이를 포함하는 전이금속 화합물을 제공하기 위한 것이다.The present invention is to provide a novel ligand compound capable of producing an olefin-based polymer with high catalytic activity and selectivity, and a transition metal compound containing the same.
상기 과제를 해결하기 위하여, 본 발명은 하기 화학식 1로 표시되는 리간드 화합물을 제공한다:In order to solve the above problems, the present invention provides a ligand compound represented by
[화학식 1][Formula 1]
상기 화학식 1에서,In
R1 내지 R19는 각각 독립적으로, 수소; C1-20 알킬; C3-20 사이클로알킬; C2-20 알케닐; C6-20 아릴; C7-20 알킬아릴; C7-20 아릴알킬; 또는 N, O 및 S로 구성되는 군으로부터 선택되는 헤테로원자를 1개 이상 포함하는 C2-20 헤테로아릴이다.R 1 to R 19 are each independently hydrogen; C 1-20 alkyl; C 3-20 cycloalkyl; C 2-20 alkenyl; C 6-20 aryl; C 7-20 alkylaryl; C 7-20 arylalkyl; Or C 2-20 heteroaryl containing one or more heteroatoms selected from the group consisting of N, O and S.
본 발명에 따른 화합물은 올레핀계 중합체 제조용 촉매로 이용될 수 있는 전이금속 화합물의 리간드로 사용될 수 있다. 보다 구체적으로, 상기 화학식 1로 표시되는 화합물은 2개의 바이페닐-2-올이 각각 메틸렌에 의해 피리딘과 연결되어 있는 구조를 갖는다. 이때, 바이페닐-2-올의 산소 원자는 후술할 전이금속 화합물에서 전이금속과 공유 결합되고, 피리딘의 질소 원자는 전이금속과 배위 결합될 수 있다. The compound according to the present invention can be used as a ligand of a transition metal compound that can be used as a catalyst for preparing an olefinic polymer. More specifically, the compound represented by
상기 화학식 1에서, R1 내지 R19는 각각 독립적으로, 수소; C1-10 알킬; C6-10 아릴; 또는 N 원자를 1개 이상 포함하는 C2-20 헤테로아릴일 수 있다.In
구체적으로, R1 내지 R19는 각각 독립적으로, 수소, tert-부틸, 페닐, 또는 카바졸일일 수 있다.Specifically, R 1 to R 19 may each independently be hydrogen, tert-butyl, phenyl, or carbazole.
더욱 구체적으로, R1, R3, R17 및 R19는 각각 독립적으로, tert-부틸, 페닐, 또는 카바졸일이고, R2, R4 내지 R16 및 R18은 수소일 수 있다. More specifically, R 1 , R 3 , R 17 and R 19 are each independently tert-butyl, phenyl, or carbazolyl, and R 2 , R 4 to R 16 and R 18 can be hydrogen.
이때, R1 및 R19는 서로 동일하고, R3 및 R17은 서로 동일할 수 있다. At this time, R 1 and R 19 are the same as each other, and R 3 and R 17 may be the same as each other.
예를 들어, R1 및 R19는 각각 독립적으로, 페닐 또는 카바졸일이고, R3 및 R17은 tert-부틸일 수 있다. For example, R 1 and R 19 can each independently be phenyl or carbazolyl, and R 3 and R 17 can be tert-butyl.
구체적으로 예를 들어, R1 및 R19는 각각 독립적으로, 페닐 또는 9H-카바졸-9-일이고, R3 및 R17은 tert-부틸일 수 있다.Specifically, for example, R 1 and R 19 may each independently be phenyl or 9H-carbazole-9-yl, and R 3 and R 17 may be tert-butyl.
상기 화학식 1로 표시되는 화합물은 하기 화학식 1A로 표시될 수 있다:The compound represented by
[화학식 1A][Formula 1A]
상기 화학식 1A에서,In Formula 1A,
R1, R3, R17 및 R19에 대한 설명은 상기 화학식 1에서 정의한 바와 같다.Description of R 1 , R 3 , R 17 and R 19 is as defined in
또한, 상기 화학식 1로 표시되는 화합물의 대표적인 예는 하기 화합물 1-1 또는 1-2일 수 있다:In addition, a typical example of the compound represented by Formula 1 may be the following Compound 1-1 or 1-2:
한편, 상기 화학식 1로 표시되는 화합물은 일례로 하기 반응식 1과 같이 제조될 수 있으나, 이에 한정되는 것은 아니다. 상기 제조 방법은 후술할 제조예에서 보다 구체화될 수 있다. Meanwhile, the compound represented by Chemical Formula 1 may be prepared as shown in
[반응식 1][Scheme 1]
상기 반응식 1에서, R1 내지 R19에 대한 설명은 앞서 화학식 1에서 정의된 바와 같다.In
상기 단계 1 및 2는, 화학식 A-1로 표시되는 화합물에 n-부틸리튬 및 ZnBr2를 순차적으로 가하여 중간체로 화학식 A-2로 표시되는 화합물을 생성한 후, 백금 촉매의 존재 하에서 화학식 A-3으로 표시되는 화합물을 가하여 화학식 A-4로 표시되는 화합물을 제조하는 단계이다. 구체적으로, 화학식 A-2로 표시되는 피리딘 유도체의 2번 및 6번 위치에 화학식 A-1로 표시되는 바이페닐계 화합물을 도입하기 위한 단계로, 상기 단계 1의 반응은 -78℃ 및 아르곤 분위기 하에서 수행되는 것이 바람직하고, 상기 단계 2의 반응은 약 24 시간 동안 환류시켜 수행되는 것이 바람직하다. In
또한, 상기 단계 3은, 화학식 A-4로 표시되는 화합물을 삼브롬화 붕소의 존재 하에서 반응시켜 상기 화학식 1로 표시되는 화합물을 제조하는 단계로서, 가수분해 반응에 의해 메톡시기 위치에 하이드록시기를 도입할 수 있다.In addition, step 3 is a step of preparing a compound represented by the formula (1) by reacting the compound represented by the formula (A-4) in the presence of boron tribromide, by introducing a hydroxyl group at the methoxy group position by a hydrolysis reaction can do.
또한, 본 발명은 하기 화학식 2로 표시되는 전이금속 화합물을 제공한다:In addition, the present invention provides a transition metal compound represented by Formula 2:
[화학식 2][Formula 2]
상기 화학식 2에서,In Chemical Formula 2,
M은 4족의 전이금속이고,M is a transition metal of group 4,
L1 및 L2는 각각 독립적으로, 할로겐, C1-20 알킬; C3-20 사이클로알킬; C2-20 알케닐; C6-20 아릴; C7-20 알킬아릴; C7-20 아릴알킬; C1-20 알킬아미노; C6-20 아릴아미노; 또는 C6-20 알킬리덴이고,L 1 and L 2 are each independently halogen, C 1-20 alkyl; C 3-20 cycloalkyl; C 2-20 alkenyl; C 6-20 aryl; C 7-20 alkylaryl; C 7-20 arylalkyl; C 1-20 alkylamino; C 6-20 arylamino; Or C 6-20 alkylidene,
R1 내지 R19는 각각 독립적으로, 수소; C1-20 알킬; C3-20 사이클로알킬; C2-20 알케닐; C6-20 아릴; C7-20 알킬아릴; C7-20 아릴알킬; 또는 N, O 및 S로 구성되는 군으로부터 선택되는 헤테로원자를 1개 이상 포함하는 C2-20 헤테로아릴이며, R 1 to R 19 are each independently hydrogen; C 1-20 alkyl; C 3-20 cycloalkyl; C 2-20 alkenyl; C 6-20 aryl; C 7-20 alkylaryl; C 7-20 arylalkyl; Or C 2-20 heteroaryl containing one or more heteroatoms selected from the group consisting of N, O and S,
여기서, →는 배위 결합을 의미한다.Here, → means coordination bond.
구체적으로, M은 Ti, Zr, 또는 Hf일 수 있다.Specifically, M may be Ti, Zr, or Hf.
또한, L1 및 L2는 각각 독립적으로, C1-10 알킬일 수 있다. 예를 들어, L1 및 L2는 메틸일 수 있다.Further, L 1 and L 2 may be each independently C 1-10 alkyl. For example, L 1 and L 2 may be methyl.
또한, R1 내지 R19는 각각 독립적으로, 수소; C1-10 알킬; C6-10 아릴; 또는 N 원자를 1개 이상 포함하는 C2-20 헤테로아릴일 수 있다.In addition, R 1 to R 19 are each independently hydrogen; C 1-10 alkyl; C 6-10 aryl; Or it may be a C 2-20 heteroaryl containing one or more N atoms.
구체적으로, R1 내지 R19는 각각 독립적으로, 수소, tert-부틸, 페닐, 또는 카바졸일일 수 있다.Specifically, R 1 to R 19 may each independently be hydrogen, tert-butyl, phenyl, or carbazole.
더욱 구체적으로, R1, R3, R17 및 R19는 각각 독립적으로, tert-부틸, 페닐, 또는 카바졸일이고, R2, R4 내지 R16 및 R18은 수소일 수 있다. More specifically, R 1 , R 3 , R 17 and R 19 are each independently tert-butyl, phenyl, or carbazolyl, and R 2 , R 4 to R 16 and R 18 can be hydrogen.
이때, R1 및 R19는 서로 동일하고, R3 및 R17은 서로 동일할 수 있다. At this time, R 1 and R 19 are the same as each other, and R 3 and R 17 may be the same as each other.
예를 들어, R1 및 R19는 페닐 또는 카바졸일이고, R3 및 R17은 tert-부틸일 수 있다. For example, R 1 and R 19 can be phenyl or carbazolyl, and R 3 and R 17 can be tert-butyl.
구체적으로 예를 들어, R1 및 R19는 페닐 또는 9H-카바졸-9-일이고, R3 및 R17은 tert-부틸일 수 있다.Specifically, for example, R 1 and R 19 may be phenyl or 9H-carbazole-9-yl, and R 3 and R 17 may be tert-butyl.
상기 화학식 2로 표시되는 화합물은 하기 화학식 2A로 표시될 수 있다:The compound represented by Chemical Formula 2 may be represented by Chemical Formula 2A:
[화학식 2A][Formula 2A]
상기 화학식 2A에서,In Formula 2A,
M, L1, L2, R1, R3, R17 및 R19에 대한 설명은 상기 화학식 2에서 정의한 바와 같다.The description of M, L 1 , L 2 , R 1 , R 3 , R 17 and R 19 is as defined in
또한, 상기 화학식 2로 표시되는 화합물의 대표적인 예는 하기 화합물 2-1 내지 2-4 중 하나일 수 있다:In addition, a typical example of the compound represented by Formula 2 may be one of the following compounds 2-1 to 2-4:
한편, 상기 화학식 2로 표시되는 화합물은 일례로 하기 반응식 2과 같이 제조될 수 있으나, 이에 한정되는 것은 아니다. 상기 제조 방법은 후술할 제조예에서 보다 구체화될 수 있다. Meanwhile, the compound represented by Chemical Formula 2 may be prepared as
[반응식 2][Scheme 2]
상기 반응식 2에서, M, L1, L2 및 R1 내지 R19에 대한 설명은 앞서 화학식 2에서 정의된 바와 같다.In
구체적으로, 상기 화학식 2로 표시되는 화합물은 화학식 1로 표시되는 화합물을 전이금속 M의 리간드로 도입하는 상기 반응을 통해 제조될 수 있다.Specifically, the compound represented by
한편, 상술한 전이금속 화합물을 포함하는 전이금속 촉매 조성물이 제공된다. 보다 구체적으로, 상기 전이금속 화합물은 단독으로 또는 상기 전이금속 화합물 이외에 조촉매를 추가로 포함하는 촉매 조성물 형태로, 올레핀계 중합체를 제조하기 위한 중합 반응의 촉매로 사용될 수 있다. 이때, 사용되는 조촉매로는 13족 금속을 포함하는 유기 금속 화합물로서, 일반적으로 전이금속 화합물의 촉매 하에 올레핀을 중합시킬 때 사용될 수 있는 것이라면 특별히 한정되지 않는다.Meanwhile, a transition metal catalyst composition including the above-described transition metal compound is provided. More specifically, the transition metal compound may be used alone or in the form of a catalyst composition further comprising a co-catalyst in addition to the transition metal compound, and may be used as a catalyst for a polymerization reaction for preparing an olefin-based polymer. At this time, the cocatalyst used is an organometallic compound containing a Group 13 metal, and is generally not particularly limited as long as it can be used when polymerizing an olefin under a catalyst of a transition metal compound.
구체적으로, 상기 전이금속 촉매 조성물은 하기 화학식 3 내지 5로 표시되는 화합물들로 이루어진 군으로부터 선택되는 어느 하나 이상의 조촉매를 더 포함할 수 있다:Specifically, the transition metal catalyst composition may further include any one or more cocatalysts selected from the group consisting of compounds represented by the following Chemical Formulas 3 to 5:
[화학식 3][Formula 3]
-[Al(R21)-O]c--[Al(R 21 )-O] c-
상기 화학식 3에서, In Chemical Formula 3,
R21은 각각 독립적으로 할로겐, C1-20 알킬 또는 C1-20 할로알킬이고, R 21 are each independently halogen, C 1-20 alkyl or C 1-20 haloalkyl,
c는 2 이상의 정수이며,c is an integer greater than or equal to 2,
[화학식 4][Formula 4]
D(R22)3 D(R 22 ) 3
상기 화학식 4에서,In Chemical Formula 4,
D는 알루미늄 또는 보론이고, D is aluminum or boron,
R22는 각각 독립적으로, 수소, 할로겐, C1-20 하이드로카빌 또는 할로겐으로 치환된 C1-20 하이드로카빌이고,R 22 are each independently hydrogen, halogen, C 1-20 hydrocarbyl or C 1-20 hydrocarbyl substituted with halogen,
[화학식 5][Formula 5]
[L-H]+[Q(E)4]- 또는 [L]+[Q(E)4]- [LH] + [Q (E ) 4] - or [L] + [Q (E ) 4] -
상기 화학식 5에서,In Chemical Formula 5,
L은 중성 또는 양이온성 루이스 염기이고, L is a neutral or cationic Lewis base,
[L-H]+는 브론스테드 산이며, [LH] + is Bronsted acid,
Q는 Br3+ 또는 Al3+이고, Q is Br 3+ or Al 3+ ,
E는 각각 독립적으로 C6-20 아릴 또는 C1-20 알킬이고, 여기서 상기 C6-20 아릴 또는 C1-20 알킬은 비치환되거나 또는 할로겐, C1-20 알킬, C1-20 알콕시 및 페녹시로 구성되는 군으로부터 선택되는 하나 이상의 치환기로 치환된다.E are each independently C 6-20 aryl or C 1-20 alkyl, wherein the C 6-20 aryl or C 1-20 alkyl is unsubstituted or halogen, C 1-20 alkyl, C 1-20 alkoxy and It is substituted with one or more substituents selected from the group consisting of phenoxy.
상기 화학식 3으로 표시되는 화합물로는, 예를 들어 개질메틸알루미녹산(MMAO), 메틸알루미녹산(MAO), 에틸알루미녹산, 이소부틸알루미녹산, 부틸알루미녹산 등이 될 수 있다.The compound represented by Chemical Formula 3 may be, for example, modified methyl aluminoxane (MMAO), methyl aluminoxane (MAO), ethyl aluminoxane, isobutyl aluminoxane, butyl aluminoxane, and the like.
상기 화학식 4로 표시되는 알킬 금속 화합물로는, 예를 들어 트리메틸알루미늄, 트리에틸알루미늄, 트리이소부틸알루미늄, 트리프로필알루미늄, 트리부틸알루미늄, 디메틸클로로알루미늄, 디메틸이소부틸알루미늄, 디메틸에틸알루미늄, 디에틸클로로알루미늄, 트리이소프로필알루미늄, 트리-s-부틸알루미늄, 트리씨클로펜틸알루미늄, 트리펜틸알루미늄, 트리이소펜틸알루미늄, 트리헥실알루미늄, 에틸디메틸알루미늄, 메틸디에틸알루미늄, 트리페닐알루미늄, 트리-p-톨릴알루미늄, 디메틸알루미늄메톡시드, 디메틸알루미늄에톡시드, 트리메틸보론, 트리에틸보론, 트리이소부틸보론, 트리프로필보론, 트리부틸보론 등일 수 있다.Examples of the alkyl metal compound represented by Chemical Formula 4 include, for example, trimethyl aluminum, triethyl aluminum, triisobutyl aluminum, tripropyl aluminum, tributyl aluminum, dimethylchloro aluminum, dimethyl isobutyl aluminum, dimethyl ethyl aluminum, and diethyl. Chloro aluminum, triisopropyl aluminum, tri-s-butyl aluminum, tricyclopentyl aluminum, tripentyl aluminum, triisopentyl aluminum, trihexyl aluminum, ethyl dimethyl aluminum, methyl diethyl aluminum, triphenyl aluminum, tri-p- Tolyl aluminum, dimethyl aluminum methoxide, dimethyl aluminum ethoxide, trimethyl boron, triethyl boron, triisobutyl boron, tripropyl boron, tributyl boron, and the like.
상기 화학식 5로 표시되는 화합물로는, 예를 들어 트리에틸암모니움테트라페닐보론, 트리부틸암모니움테트라페닐보론, 트리메틸암모니움테트라페닐보론, 트리프로필암모니움테트라페닐보론, 트리메틸암모니움테트라(p-톨릴)보론, 트리프로필암모니움테트라(p-톨릴)보론, 트리에틸암모니움테트라(o,p-디메틸페닐)보론, 트리메틸암모니움테트라(o,p-디메틸페닐)보론, 트리부틸암모니움테트라(p-트리플루오로메틸페닐)보론, 트리메틸암모니움테트라(p-트리플로로메틸페닐)보론, 트리부틸암모니움테트라펜타플루오로페닐보론, N,N-디에틸아닐리니움테트라페닐 보론, N,N-디에틸아닐리니움테트라페닐보론, N,N-디에틸아닐리니움테트라펜타플루오로페닐보론, 디에틸암모니움테트라펜타플루오로페닐보론, 트리페닐포스포늄테트라페닐보론, 트리메틸포스포늄테트라페닐보론, 트리에틸암모니움테트라페닐알루미늄, 트리부틸암모니움테트라페닐알루미늄, 트리메틸암모니움테트라페닐알루미늄, 트리프로필암모니움테트라페닐알루미늄, 트리메틸암모니움테트라(p-톨릴)알루미늄, 트리프로필암모니움테트라(p-톨릴)알루미늄, 트리에틸암모니움테트라(o,p-디메틸페닐)알루미늄, 트리부틸암모니움테트라(p-트리플루오로메틸페닐)알루미늄, 트리메틸암모니움테트라(p-트리플루오로메틸페닐)알루미늄,트리부틸암모니움테트라펜타플루오로페닐알루미늄, N,N-디에틸아닐리니움테트라페닐알루미늄, N,N-디에틸아닐리니움테트라페닐알루미늄, N,N-디에틸아닐리니움테트라펜타플로로페닐알루미늄, 디에틸암모니움테트라펜타플루오로페닐알루미늄, 트리페닐포스포늄테트라페닐알루미늄, 트리메틸포스포늄테트라페닐알루미늄, 트리페닐카보니움테트라페닐보론, 트리페닐카보니움테트라페닐알루미늄, 트리페닐카보니움테트라(p-트리플로로메틸페닐)보론, 트리페닐카보니움테트라펜타플루오로페닐보론 등일 수 있다.Examples of the compound represented by Formula 5 include, for example, triethylammonium tetraphenylboron, tributylammonium tetraphenylboron, trimethylammonium tetraphenylboron, tripropylammonium tetraphenylboron, and trimethylammoniumtetra(p -Tolyl) boron, tripropyl ammonium tetra (p-tolyl) boron, triethyl ammonium tetra (o,p-dimethylphenyl) boron, trimethyl ammonium tetra (o, p-dimethylphenyl) boron, tributyl ammonium Tetra(p-trifluoromethylphenyl)boron, trimethylammoniumtetra(p-trifluoromethylphenyl)boron, tributylammoniumtetrapentafluorophenylboron, N,N-diethylaniliniumtetraphenyl boron, N ,N-diethylanilinium tetraphenylboron, N,N-diethylanilinium tetrapentafluorophenylboron, diethylammoniumtetrapentafluorophenylboron, triphenylphosphoniumtetraphenylboron, trimethylphosphonium Tetraphenylboron, triethylammoniumtetraphenylaluminum, tributylammoniumtetraphenylaluminum, trimethylammoniumtetraphenylaluminum, tripropylammoniumtetraphenylaluminum, trimethylammoniumtetra(p-tolyl)aluminum, tripropylammonium Tetra(p-tolyl)aluminum, triethylammoniumtetra(o,p-dimethylphenyl)aluminum, tributylammoniumtetra(p-trifluoromethylphenyl)aluminum, trimethylammoniumtetra(p-trifluoromethylphenyl) Aluminum, tributylammonium tetrapentafluorophenylaluminum, N,N-diethylanilinium tetraphenylaluminum, N,N-diethylanilinium tetraphenylaluminum, N,N-diethylanilinium tetrapenta Florophenyl aluminum, diethyl ammonium tetrapentafluorophenyl aluminum, triphenylphosphonium tetraphenyl aluminum, trimethylphosphonium tetraphenyl aluminum, triphenylcarbonium tetraphenyl boron, triphenylcarbonium tetraphenyl aluminum, tri Phenylcarbonium tetra(p-trifluoromethylphenyl) boron, triphenylcarbonium tetrapentafluorophenylboron, and the like.
보다 구체적으로, 상기 촉매 조성물은 조촉매로 메틸알루미녹산, 트리메틸알루미늄, 트리에틸알루미늄, 트리이소부틸알루미늄, 또는 메틸알룸옥산(MAO)을 사용할 수 있다. More specifically, the catalyst composition may use methyl aluminoxane, trimethyl aluminum, triethyl aluminum, triisobutyl aluminum, or methyl alumoxane (MAO) as a cocatalyst.
상기 조촉매의 사용 함량은 목적하는 촉매 조성물의 물성 또는 효과에 따라 적절하게 조절될 수 있다. The use content of the co-catalyst can be appropriately adjusted according to the properties or effects of the desired catalyst composition.
상기 촉매 조성물은 상기 전이금속 화합물과 조촉매 화합물을 담체에 담지된 형태로 포함할 수 있다. 상기 화학식 2로 표시되는 전이 금속 화합물은 상술한 구조적 특징을 가져 담체에 안정적으로 담지될 수 있다. 또한, 이러한 전이 금속 화합물이 담지된 담지 촉매는 올레핀 중합에 높은 활성을 나타낼 수 있다. The catalyst composition may include the transition metal compound and the cocatalyst compound in a form supported on a carrier. The transition metal compound represented by
상기 담체로는 표면에 하이드록시기 또는 실록산기를 함유하는 담체를 사용할 수 있다. 구체적으로, 상기 담체로는 고온에서 건조하여 표면에 수분을 제거함으로써 반응성이 큰 하이드록시기 또는 실록산기를 함유하는 담체를 사용할 수 있다. 보다 구체적으로, 상기 담체로는 실리카, 알루미나, 마그네시아 또는 이들의 혼합물 등을 사용할 수 있다. 상기 담체는 고온에서 건조된 것일 수 있고, 이들은 통상적으로 Na2O, K2CO3, BaSO4 및 Mg(NO3)2 등의 산화물, 탄산염, 황산염, 질산염 성분을 포함할 수 있다.As the carrier, a carrier containing a hydroxy group or a siloxane group on the surface may be used. Specifically, as the carrier, a carrier containing a hydroxy group or a siloxane group having high reactivity may be used by drying at a high temperature to remove moisture on the surface. More specifically, as the carrier, silica, alumina, magnesia or a mixture thereof can be used. The carrier may be dried at a high temperature, and these may typically include oxides, carbonates, sulfates, and nitrate components such as Na2O, K2CO3, BaSO4, and Mg(NO3)2.
한편, 상기 전이금속 화합물을 포함하는 촉매 조성물의 존재 하에, 올레핀계 단량체를 중합 반응시키는 단계를 포함하는 올레핀계 중합체의 제조 방법이 제공된다. On the other hand, in the presence of a catalyst composition comprising the transition metal compound, a method for producing an olefin-based polymer comprising the step of polymerizing an olefin-based monomer is provided.
상기 합성되는 올레핀계 중합체의 예가 특별히 제한되는 것은 아니나, 예를 들어 올레핀 단독 중합체, 올레핀 공중합체 또는 에틸렌/알파-올레핀 공중합체일 수 있다.Examples of the synthesized olefin-based polymer are not particularly limited, but may be, for example, an olefin homopolymer, an olefin copolymer, or an ethylene/alpha-olefin copolymer.
상기 올레핀계 단량체의 구체적인 예로는 에틸렌, 알파-올레핀, 사이클릭 올레핀 등이 있으며, 이중 결합을 2개 이상 가지고 있는 다이엔 올레핀계 단량체 또는 트라이엔 올레핀계 단량체 등도 중합 가능하다. 상기 단량체의 구체적인 예로는 에틸렌, 프로필렌, 1-부텐, 1-펜텐, 4-메틸-1-펜텐, 1-헥센, 1-헵텐, 1-옥텐, 1-데센, 1-운데센, 1-도데센, 1-테트라데센, 1-헥사데센, 1-아이토센, 노보넨, 노보나디엔, 에틸리덴노보넨, 페닐노보넨, 비닐노보넨, 디사이클로펜타디엔, 1,4-부타디엔, 1,5-펜타디엔, 1,6-헥사디엔, 스티렌, 알파-메틸스티렌, 디비닐벤젠, 3-클로로메틸스티렌 등이 있으며, 이들 단량체를 2 종 이상 혼합하여 공중합할 수도 있다.Specific examples of the olefinic monomer include ethylene, alpha-olefin, cyclic olefin, and the like, and diene olefin monomer or triene olefin monomer having two or more double bonds can also be polymerized. Specific examples of the monomers are ethylene, propylene, 1-butene, 1-pentene, 4-methyl-1-pentene, 1-hexene, 1-heptene, 1-octene, 1-decene, 1-undecene, 1-dode Sen, 1-tetradecene, 1-hexadecene, 1-atocene, norbornene, norbornadiene, ethylidene norbornene, phenyl norbornene, vinyl norbornene, dicyclopentadiene, 1,4-butadiene, 1, 5-pentadiene, 1,6-hexadiene, styrene, alpha-methylstyrene, divinylbenzene, 3-chloromethylstyrene, and the like, and may be copolymerized by mixing two or more of these monomers.
상기 올레핀 단량체의 중합 반응은 연속식 용행 중합 공정, 벌크 중합 공정, 현탁 중합 공정 또는 유화 중합 공정등으로 제한 없이 진행될 수 있으나, 예를 들어 단일 반응기에서 이루어지는 용액 공중합(solution polymerization) 반응 또는 담지 공중합 반응에 의할 수 있다. 상기 용액 공중합 반응은 상기 전이금속 촉매 조성물을 용매에 직접 녹여 용액 상태로 이루어지며, 상기 담지 공중합 반응은 상기 전이금속 촉매 조성물을 상술한 담체에 담지시켜 담지 촉매를 제조한 후, 상기 담지 촉매를 용매에 투입하여 슬러리 상태로 이루어 질 수 있다.The polymerization reaction of the olefin monomer may be performed without limitation in a continuous solvent polymerization process, a bulk polymerization process, a suspension polymerization process, or an emulsion polymerization process, but for example, a solution polymerization reaction or a supported copolymerization reaction performed in a single reactor. Can be by The solution copolymerization reaction consists of dissolving the transition metal catalyst composition directly in a solvent in a solution state, and the supported copolymerization reaction is carried by preparing the supported catalyst by supporting the transition metal catalyst composition on the above-described carrier, and then the supported catalyst is solvent. It can be made into a slurry state by putting in.
상기 올레핀계 단량체의 중합 반응은 45 내지 200의 온도, 또는 60 내지 150 에서, 0.1 시간 내지 2.5 시간, 또는 0.1 시간 내지 1.3 시간 동안 이루어 질 수 있다. 또한, 압력은 1 bar 내지 50 bar, 또는 2 bar 내지 45 bar에서 진행될 수 있다. 구체적으로 상기 용액 공중합 반응은 1 bar 내지 50 bar의 압력, 60 내지 150의 온도에서 0.1 시간 내지 1 시간 동안 진행될 수 있고, 상기 담지 공중합 반응은 1 bar 내지 50 bar의 압력, 60 내지 90의 온도에서 0.5 시간 내지 2.5 시간 동안 진행될 수 있다.The polymerization reaction of the olefinic monomer may be performed at a temperature of 45 to 200, or 60 to 150, for 0.1 hour to 2.5 hours, or 0.1 hour to 1.3 hours. In addition, the pressure can be carried out at 1 bar to 50 bar, or 2 bar to 45 bar. Specifically, the solution copolymerization reaction may be performed at a pressure of 1 bar to 50 bar, a temperature of 60 to 150 for 0.1 hour to 1 hour, and the supported copolymerization reaction may be performed at a pressure of 1 bar to 50 bar, and a temperature of 60 to 90 0.5 hour to 2.5 hours.
상기 중합 반응에서 사용되는 반응기에는 별 다른 제한이 없으나, 예를 들어 연속 교반식 반응기(CSTR) 또는 연속 흐름식 반응기(PFR)를 사용할 수 있다. 상기 중합 반응에서 반응기는 2개 이상 직렬 혹은 병렬로 배열될 수 있고, 반응 혼합물로부터 용매 및 미반응 단량체를 연속적으로 분리하기 위한 분리기를 추가적으로 포함할 수 있다.The reactor used in the polymerization reaction is not particularly limited, but for example, a continuous stirred reactor (CSTR) or a continuous flow reactor (PFR) may be used. In the polymerization reaction, two or more reactors may be arranged in series or in parallel, and may further include a separator for continuously separating solvent and unreacted monomers from the reaction mixture.
본 발명의 신규한 리간드 화합물 및 이를 포함하는 전이금속 화합물은 올레핀계 중합체의 제조에 있어 중합 반응의 촉매로 유용하게 사용될 수 있다.The novel ligand compound of the present invention and the transition metal compound containing the same can be usefully used as a catalyst for polymerization reaction in the production of olefin-based polymers.
도 1은 실시예 3에서 합성한 전이금속 화합물 2-1의 1H NMR spectrum을 나타낸 것이다.
도 2는 실시예 4에서 합성한 전이금속 화합물 2-2의 1H NMR spectrum을 나타낸 것이다.
도 3은 실시예 5에서 합성한 전이금속 화합물 2-3의 1H NMR spectrum을 나타낸 것이다.
도 4는 실시예 6에서 합성한 전이금속 화합물 2-4의 1H NMR spectrum을 나타낸 것이다. 1 is a 1 H NMR spectrum of the transition metal compound 2-1 synthesized in Example 3.
Figure 2 shows the 1 H NMR spectrum of the transition metal compound 2-2 synthesized in Example 4.
Figure 3 shows the 1 H NMR spectrum of the transition metal compound 2-3 synthesized in Example 5.
Figure 4 shows the 1 H NMR spectrum of the transition metal compound 2-4 synthesized in Example 6.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 이에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred embodiments are provided to help understanding of the present invention. However, the following examples are only provided to more easily understand the present invention, and the contents of the present invention are not limited thereby.
실시예Example 1: 화합물 1-1의 합성 1: Synthesis of Compound 1-1
단계 (a): 2-Step (a): 2- 브로모Bromo -4--4- terttert -- 부틸페놀Butylphenol (2-(2- bromobromo -4--4- terttert -- butylphenolbutylphenol )의 제조)
클로로포름(15 mL)에 용해되어 있는 브로민(10 g, 62.5 mmol) 용액을 0 ℃ 및 아르곤 하에 있는 1:1 v/v 클로로폼:사염화탄소(30 mL)에 용해되어 있는 4-tert-부틸페놀(8.48 g, 56.5 mmol) 용액으로 2시간 동안 천천히 가하였다. 반응 혼합액은 하룻밤 동안 교반되었다. 반응 혼합액을 디클로로메탄(50 mL)로 희석시키고 1% Na2SO3 수용액 및 브라인으로 씻어주었다. 유기층을 모아 Na2SO4 처리하고 여과한 후 증발하였다. 잔류물을 플래시 크로마토그래피(용리제: 노말-헥산)로 정제하여 2-브로모-4-tert-부틸페놀을 얻었다. 수율 8.04 g(62%).4-tert-butylphenol dissolved in 1:1 v/v chloroform:carbon tetrachloride (30 mL) at 0° C. and argon in a solution of bromine (10 g, 62.5 mmol) dissolved in chloroform (15 mL). (8.48 g, 56.5 mmol) solution was slowly added over 2 hours. The reaction mixture was stirred overnight. The reaction mixture was diluted with dichloromethane (50 mL) and washed with 1% Na 2 SO 3 aqueous solution and brine. The combined organic layers were treated with Na 2 SO 4 , filtered, and evaporated. The residue was purified by flash chromatography (eluent: normal-hexane) to obtain 2-bromo-4-tert-butylphenol. Yield 8.04 g (62%).
1H NMR (600 MHz, CDCl3, ppm): 1.29 (s, 9 H), 6.96 (d, J=8.47 Hz, 1 H), 7.25 (dd, J=9.04, 1.64 Hz, 1 H), 7.45 (d, J=2.22 Hz, 1 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.29 (s, 9 H), 6.96 (d, J=8.47 Hz, 1 H), 7.25 (dd, J=9.04, 1.64 Hz, 1 H), 7.45 (d, J=2.22 Hz, 1 H).
단계 (b): 2-Step (b): 2- 브로모Bromo -4--4- terttert -부틸-1--Butyl-1- 메톡시벤젠Methoxybenzene (2-(2- bromobromo -4--4- terttert -butyl-1-methoxybenzene)의 제조-butyl-1-methoxybenzene)
상기 단계 (a)에서 제조한 2-브로모-4-tert-부틸페놀(8.04 g), 무수 K2CO3(11.6 g) 및 무수 아세톤(120 mL)의 혼합액에 메틸 아이오다이드(6.23 g)를 천천히 가하였다. 반응 혼합액을 하룻밤 동안 환류시킨 후 상온으로 냉각하고 여과하였다. 여과액을 증발시킨 후 컬럼 크로마토그래피(용리제: 노말-헥산)로 정제하여 2-브로모-4-tert-부틸-1-메톡시벤젠을 얻었다. 수율 8.27 g(97%).Methyl iodide (6.23 g) in a mixture of 2-bromo-4-tert-butylphenol (8.04 g), anhydrous K 2 CO 3 (11.6 g) and acetone anhydrous (120 mL) prepared in step (a) above. ) Was added slowly. The reaction mixture was refluxed overnight, then cooled to room temperature and filtered. After evaporating the filtrate, it was purified by column chromatography (eluent: normal-hexane) to obtain 2-bromo-4-tert-butyl-1-methoxybenzene. Yield 8.27 g (97%).
1H NMR (600 MHz, CDCl3, ppm): 1.31 (s, 10 H), 3.89 (s, 3 H), 6.85 (d, J=8.55 Hz, 1 H), 7.29 (dd, J=8.55, 2.38 Hz, 1 H), 7.56 (d, J=2.38 Hz, 1 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.31 (s, 10 H), 3.89 (s, 3 H), 6.85 (d, J=8.55 Hz, 1 H), 7.29 (dd, J=8.55, 2.38 Hz, 1 H), 7.56 (d, J=2.38 Hz, 1 H).
단계 (c): 5-Step (c): 5- terttert -부틸-2--Butyl-2- 메톡시바이페닐Methoxybiphenyl (5-(5- terttert -butyl-2--butyl-2- methoxybiphenylmethoxybiphenyl )의 제조)
상기 단계 (b)에서 제조한 2-브로모-4-tert-부틸-1-메톡시벤젠(6.8 g), 페닐보론산(3.6 g), NaHCO3 (7.2 g), 테트라부틸암모늄 브로마이드(860 mg), (6Dipp)Pd(cinn)Cl(90 mg)을 증류수(42 mL)에 가하고 한 시간 동안 환류시켰다. 반응 용액을 디클로로메탄(50 mL x 3회)으로 추출하고 유기층을 모아 증발한 후 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 1:1)로 정제하여 5-tert-부틸-2-메톡시바이페닐을 얻었다. 수율 6.31 g(94%).2-bromo-4-tert-butyl-1-methoxybenzene (6.8 g), phenylboronic acid (3.6 g), NaHCO 3 (7.2 g), tetrabutylammonium bromide (860) prepared in step (b) above mg), (6Dipp)Pd(cinn)Cl (90 mg) was added to distilled water (42 mL) and refluxed for 1 hour. The reaction solution was extracted with dichloromethane (50 mL x 3 times), the organic layers were collected and evaporated, and the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane = 1:1) to 5-tert-butyl. 2-Methoxybiphenyl was obtained. Yield 6.31 g (94%).
1H NMR (600 MHz, DMSO-d 6, ppm): 1.29 (s, 9 H), 3.73 (s, 3 H), 7.02 (d, J=8.63 Hz, 1 H), 7.24 (d, J=2.55 Hz, 1 H), 7.29 - 7.36 (m, 2 H), 7.39 (t, J=7.60 Hz, 2 H), 7.46 (d, J=7.89 Hz, 2 H). 1 H NMR (600 MHz, DMSO- d 6 , ppm): 1.29 (s, 9 H), 3.73 (s, 3 H), 7.02 (d, J=8.63 Hz, 1 H), 7.24 (d, J= 2.55 Hz, 1 H), 7.29-7.36 (m, 2 H), 7.39 (t, J=7.60 Hz, 2 H), 7.46 (d, J=7.89 Hz, 2 H).
단계 (d): 3-Step (d): 3- 브로모Bromo -5--5- terttert -부틸-2--Butyl-2- 메톡시바이페닐Methoxybiphenyl (3-(3- bromobromo -5--5- terttert -butyl-2-methoxybiphenyl)의 제조-butyl-2-methoxybiphenyl)
상기 단계 (c)에서 제조한 5-tert-부틸-2-메톡시바이페닐(9.22 g, 38 mmol)을 디클로로메탄(200 mL)로 용해시키고 0 ℃로 냉각시킨 후 디클로로메탄(40 mL)에 용해되어 있는 브로민(6.3 g) 용액을 두 시간 동안 천천히 가하였다. 이 후 NaHCO3 수용액(100 mL)을 가하여 반응을 종결시키고 디클로로메탄(100 mL x 3회)으로 추출한 후 유기층을 모아 증발시켰다. 잔류물을 컬럼 크로마토그래피(용리제: 디클로로메탄:노말-헥산 = 1:5)로 정제하여 3-브로모-5-tert-부틸-2-메톡시바이페닐을 얻었다. 수율 10.2 g(83%).The 5-tert-butyl-2-methoxybiphenyl (9.22 g, 38 mmol) prepared in step (c) was dissolved in dichloromethane (200 mL) and cooled to 0° C., followed by dichloromethane (40 mL). The dissolved bromine (6.3 g) solution was slowly added for 2 hours. Thereafter, an aqueous NaHCO 3 solution (100 mL) was added to terminate the reaction, extracted with dichloromethane (100 mL x 3 times), and the organic layers were collected and evaporated. The residue was purified by column chromatography (eluent: dichloromethane:normal-hexane = 1:5) to obtain 3-bromo-5-tert-butyl-2-methoxybiphenyl. Yield 10.2 g (83%).
1H NMR (600 MHz, DMSO-d 6, ppm): 1.28 (s, 9 H) 3.31 (s, 3 H) 7.30 (d, J=2.48 Hz, 1 H) 7.36 - 7.41 (m, 1 H) 7.45 (t, J=7.57 Hz, 2 H) 7.50 - 7.54 (m, 2 H) 7.57 (d, J=2.38 Hz, 1 H). 1 H NMR (600 MHz, DMSO- d 6 , ppm): 1.28 (s, 9 H) 3.31 (s, 3 H) 7.30 (d, J=2.48 Hz, 1 H) 7.36-7.41 (m, 1 H) 7.45 (t, J=7.57 Hz, 2 H) 7.50-7.54 (m, 2 H) 7.57 (d, J=2.38 Hz, 1 H).
단계 (e): 3-(4-Step (e): 3-(4- 톨릴Tolyl )-5-)-5- terttert -부틸-2--Butyl-2- 메톡시바이페닐(3-(4-tolyl)Methoxybiphenyl (3-(4-tolyl) -5--5- terttert -butyl-2-methoxybiphenyl)의 제조-butyl-2-methoxybiphenyl)
상기 단계 (d)에서 제조한 3-브로모-5-tert-부틸-2-메톡시바이페닐(1 g, 3.13 mmol), 4-톨릴보론산(500 mg, 3.67 mmol), NaHCO3(790 mg, 9.4 mmol), 테트라부틸암모늄 브로마이드(100 mg, 0.31 mmol), (6Dipp)Pd(cinn)Cl (10 mg, 0.015 mmol)을 증류수(3 mL)에 가한 후 한 시간 동안 환류시켰다. 반응액을 디클로로메탄(50 mL x 3회)으로 추출하고 유기층을 모아 증발한 후 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 10:1)로 정제하여 3-(4-톨릴)-5-tert-부틸-2-메톡시바이페닐을 얻었다. 수율 0.98 g(95%).3-bromo-5-tert-butyl-2-methoxybiphenyl (1 g, 3.13 mmol), 4-tolylboronic acid (500 mg, 3.67 mmol), NaHCO 3 (790) prepared in step (d) above. mg, 9.4 mmol), tetrabutylammonium bromide (100 mg, 0.31 mmol), (6Dipp)Pd(cinn)Cl (10 mg, 0.015 mmol) was added to distilled water (3 mL) and refluxed for 1 hour. The reaction solution was extracted with dichloromethane (50 mL x 3 times), the organic layers were collected and evaporated, and the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane = 10:1) to 3-(4- Tolyl)-5-tert-butyl-2-methoxybiphenyl was obtained. Yield 0.98 g (95%).
1H NMR (600 MHz, DMSO-d 6, ppm): 1.31 (s, 9 H) 2.17 (s, 3 H) 2.98 (s, 3 H) 7.13 (d, J=2.57 Hz, 1 H) 7.19 - 7.33 (m, 5 H) 7.35 (t, J=7.38 Hz, 1 H) 7.44 (t, J=7.70 Hz, 2 H) 7.53 - 7.57 (m, 2 H). 1 H NMR (600 MHz, DMSO- d 6 , ppm): 1.31 (s, 9 H) 2.17 (s, 3 H) 2.98 (s, 3 H) 7.13 (d, J=2.57 Hz, 1 H) 7.19- 7.33 (m, 5 H) 7.35 (t, J=7.38 Hz, 1 H) 7.44 (t, J=7.70 Hz, 2 H) 7.53-7.57 (m, 2 H).
단계 (f): 2-(Step (f): 2-( 브로모메틸Bromomethyl )-5'-()-5'-( terttert -부틸)-2'--Butyl)-2'- 메톡시Methoxy -1,1':3',1''--1,1':3',1''- 터페닐(2-(bromomethyl)-5'-Terphenyl(2-(bromomethyl)-5'- (tert-butyl)-2'-methoxy-1,1':3',1''-terphenyl)의 제조Preparation of (tert-butyl)-2'-methoxy-1,1':3',1''-terphenyl)
상기 단계 (e)에서 제조한 3-(4-톨릴)-5-tert-부틸-2-메톡시바이페닐(4.15 g, 12.6 mmol)과 N-브로모숙신이미드(2.46 g, 13.8 mmol)을 사염화탄소(100 mL)로 용해시키고 가열하여 환류시킨 후 벤조일 퍼옥사이드(140 mg, 0.58 mmol)을 여러 번 나누어 가하였다. 반응 혼합액을 2시간 동안 환류시킨 후 증발시켜 용매를 제거하였다. 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산)로 정제하여 2-(브로모메틸)-5'-(tert-부틸)-2'-메톡시-1,1':3',1''-터페닐을 얻었다. 수율 4.06 g(79%).3-(4-tolyl)-5-tert-butyl-2-methoxybiphenyl (4.15 g, 12.6 mmol) and N -bromosuccinimide (2.46 g, 13.8 mmol) prepared in step (e) above. Was dissolved in carbon tetrachloride (100 mL), heated to reflux, and benzoyl peroxide (140 mg, 0.58 mmol) was added several times. The reaction mixture was refluxed for 2 hours, and then evaporated to remove the solvent. The residue was purified by column chromatography (eluent: normal-hexane) to 2-(bromomethyl)-5'-(tert-butyl)-2'-methoxy-1,1':3',1''-Terphenyl was obtained. Yield 4.06 g (79%).
1H NMR (600 MHz, DMSO-d 6, ppm): 1.33 (s, 9 H), 3.00 (s, 3 H), 4.43 (d, J=9.72 Hz, 1 H), 4.71 (d, J=9.81 Hz, 1 H), 7.28 - 7.48 (m, 8 H), 7.53 - 7.71 (m, 3 H). 1 H NMR (600 MHz, DMSO- d 6 , ppm): 1.33 (s, 9 H), 3.00 (s, 3 H), 4.43 (d, J=9.72 Hz, 1 H), 4.71 (d, J= 9.81 Hz, 1 H), 7.28-7.48 (m, 8 H), 7.53-7.71 (m, 3 H).
단계 (g): 2,6-비스((5'-tert-부틸)-2'-메톡시-[1,1':3',1''-터페닐]-2-일)메틸)피리딘(2,6-bis((5'-(tert-butyl)-2'-methoxy-[1,1':3',1''-terphenyl]-2-yl)methyl)pyridine)의 제조Step (g): 2,6-bis((5'-tert-butyl)-2'-methoxy-[1,1':3',1''-terphenyl]-2-yl)methyl)pyridine Preparation of (2,6-bis((5'-(tert-butyl)-2'-methoxy-[1,1':3',1''-terphenyl]-2-yl)methyl)pyridine)
-78℃ 및 아르곤 하에 있는 무수 테트라하이드로퓨란(20 mL)에 용해된 상기 단계 (f)에서 제조한 2-(브로모메틸)-5'-(tert부틸)-2'-메톡시-1,1':3',1''-터페닐(1.19 g, 2.91 mmol) 용액에 노말-헥산에 용해된 2.5 M 노말-부틸리튬 용액(1.4 mL, 3.5 mmol)을 천천히 가하였다. 이 후 반응 용액을 같은 온도에서 한 시간 동안 교반하였다. 이 후 무수 테트라하이드로퓨란(6 mL)에 용해된 ZnBr2(920 mg, 4.1 mmol) 용액을 천천히 가하였다. 반응 용액을 -78℃에서 10분 간 교반한 후 상온으로 데우고 한 시간 동안 추가 교반하였다. 2,6-디브로모피리딘(344 mg, 1.45 mmol)과 PdCl2(PPh3)2(21 mg, 0.03 mmol)을 가한 후 하룻밤 동안 환류시켰다. 상온으로 냉각시킨 후 증류수(50 mL)를 가하여 반응을 종결시켰다. 초산에틸(100 mL x 3회)로 추출하고 유기층을 모아 증발시킨 후 잔류물을 컬럼 크로마토그래피(용리제:노말-헥산:디클로로 메탄 = 5:1)로 정제하여 2,6-비스((5'-tert-부틸)-2'-메톡시-[1,1':3',1''-터페닐]-2-일)메틸)피리딘을 얻었다. 수율 860 mg(80%).2-(bromomethyl)-5'-(tertbutyl)-2'-methoxy-1 prepared in step (f) above dissolved in anhydrous tetrahydrofuran (20 mL) at -78 °C and argon, To a solution of 1':3',1''-terphenyl (1.19 g, 2.91 mmol) was slowly added a 2.5 M normal-butyllithium solution (1.4 mL, 3.5 mmol) dissolved in normal-hexane. Thereafter, the reaction solution was stirred at the same temperature for one hour. Then, a solution of ZnBr 2 (920 mg, 4.1 mmol) dissolved in anhydrous tetrahydrofuran (6 mL) was slowly added. The reaction solution was stirred at -78°C for 10 minutes, then warmed to room temperature and stirred for an additional hour. After adding 2,6-dibromopyridine (344 mg, 1.45 mmol) and PdCl 2 (PPh 3 ) 2 (21 mg, 0.03 mmol), the mixture was refluxed overnight. After cooling to room temperature, distilled water (50 mL) was added to terminate the reaction. After extraction with ethyl acetate (100 mL x 3 times), the organic layer was collected and evaporated, and the residue was purified by column chromatography (eluent: normal-hexane: dichloromethane = 5:1) to obtain 2,6-bis((5 '-tert-Butyl)-2'-methoxy-[1,1':3',1''-terphenyl]-2-yl)methyl)pyridine was obtained. Yield 860 mg (80%).
단계 (h): 화합물 1-1의 제조Step (h): Preparation of compound 1-1
상기 단계 (g)에서 제조한 2,6-비스((5'-tert부틸)-2'-메톡시-[1,1':3',1''-터페닐]-2-일)메틸)피리딘(850 mg, 1.15 mmol)을 무수 디클로로메탄(20 mL)로 용해시킨 후 -78℃로 냉각시켰다. 디클로로메탄(5 mL)에 용해된 BBr3(2.36 g, 9.44 mmol) 용액을 천천히 가하였다. 반응 혼합액을 상온으로 데우고 하룻밤 동안 교반시킨 후 증류수(50 mL)를 천천히 가하여 반응을 종결시켰다. 디클로로메탄(100 mL x 3회)으로 추출하고 유기층을 모아 증발한 후 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 4:1)로 정제하여 화합물 1-1을 얻었다. 수율 623 mg(76%)2,6-bis((5'-tertbutyl)-2'-methoxy-[1,1':3',1''-terphenyl]-2-yl)methyl prepared in step (g) above ) Pyridine (850 mg, 1.15 mmol) was dissolved in anhydrous dichloromethane (20 mL) and then cooled to -78 °C. A solution of BBr 3 (2.36 g, 9.44 mmol) in dichloromethane (5 mL) was added slowly. The reaction mixture was warmed to room temperature, stirred overnight, and distilled water (50 mL) was slowly added to terminate the reaction. The mixture was extracted with dichloromethane (100 mL x 3 times), and the combined organic layers were evaporated, and the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane = 4:1) to obtain compound 1-1. Yield 623 mg (76%)
1H NMR (600 MHz, CDCl3, ppm): 1.37 (d, J=4.95 Hz, 18 H), 2.61 - 2.80 (m, 4 H), 4.83 (s, 1 H), 4.87 (s, 1 H), 6.86 (dd, J=16.05, 7.34 Hz, 2 H), 7.15 (d, J=1.56 Hz, 2 H), 7.20 - 7.32 (m, 6 H), 7.35 - 7.42 (m, 4 H), 7.47 (dt, J=11.94, 7.65 Hz, 4 H), 7.60 (dd, J=16.51, 7.34 Hz, 4 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.37 (d, J=4.95 Hz, 18 H), 2.61-2.80 (m, 4 H), 4.83 (s, 1 H), 4.87 (s, 1 H ), 6.86 (dd, J=16.05, 7.34 Hz, 2 H), 7.15 (d, J=1.56 Hz, 2 H), 7.20-7.32 (m, 6 H), 7.35-7.42 (m, 4 H), 7.47 (dt, J=11.94, 7.65 Hz, 4 H), 7.60 (dd, J=16.51, 7.34 Hz, 4 H).
실시예Example 2: 화합물 1-2의 합성 2: Synthesis of Compound 1-2
단계 (a): 9-(5-Step (a): 9-(5- terttert -부틸-2--Butyl-2- 메톡시페닐Methoxyphenyl )-9)-9 HH -- 카바졸Carbazole (9-(5-(9-(5- terttert -butyl-2-methoxyphenyl)-9-butyl-2-methoxyphenyl)-9 HH -carbazole)의 제조-carbazole)
2-브로모-4-tert-부틸-1-메톡시벤젠(8.2 g, 33.75 mmol), 카바졸(6.75 g, 40.5 mmol), K3PO4(12.52 g), CuI(320 mg) 및 1,2-디아미노시클로헥산(770 mg)을 무수 1,4-디옥산(100 mL)로 용해시킨 후 아르곤 분위기에서 3일 동안 환류시켰다. 반응 혼합액을 상온으로 냉각시키고 증류수(100 mL) 및 초산 에틸(100 mL)을 가하여 추출한 후 유기층을 분리하였다. 물층은 초산 에틸(100 mL x 3회)로 씻어주었다. 유기층을 모아 증발시킨 후 잔류물은 컬럼 크로마토그래피(용리제: 노말-헥산:초산 에틸 = 10:1)로 정제하여 9-(5-tert-부틸-2-메톡시페닐)-9H-카바졸을 얻었다. 수율 11.0 g(99%).2-bromo-4-tert-butyl-1-methoxybenzene (8.2 g, 33.75 mmol), carbazole (6.75 g, 40.5 mmol), K 3 PO 4 (12.52 g), CuI (320 mg) and 1 ,2-Diaminocyclohexane (770 mg) was dissolved in
1H NMR (600 MHz, CDCl3, ppm): 1.37 (s, 9 H), 3.70 (s, 3 H), 7.12 (d, J=8.55 Hz, 1 H), 7.19 (m, J=8.14 Hz, 2 H), 7.27 - 7.31 (m, 2 H), 7.39 - 7.44 (m, 2 H), 7.48 - 7.52 (m, 2 H), 8.17 (m, J=7.73 Hz, 2 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.37 (s, 9 H), 3.70 (s, 3 H), 7.12 (d, J=8.55 Hz, 1 H), 7.19 (m, J=8.14 Hz , 2 H), 7.27-7.31 (m, 2 H), 7.39-7.44 (m, 2 H), 7.48-7.52 (m, 2 H), 8.17 (m, J=7.73 Hz, 2 H).
단계 (b): 5'-tert-부틸-3'-(9Step (b): 5'-tert-butyl-3'-(9 HH -카바졸-9-일)-2'-메톡시바이페닐-2-카브알데하이드(5'-tert-butyl-3'-(9-Carbazole-9-yl)-2'-methoxybiphenyl-2-carbaldehyde(5'-tert-butyl-3'-(9 HH -carbazol-9-yl)-2'-methoxybiphenyl-2-carbaldehyde)의 제조Preparation of -carbazol-9-yl)-2'-methoxybiphenyl-2-carbaldehyde)
상기 단계 (a)에서 제조한 9-(5-tert-부틸-2-메톡시페닐)-9H-카바졸(1.64 g, 4.97 mmol)을 무수 디에틸 에테르(15 mL)로 용해시킨 후 아르곤 분위기 하에서 노말-헥산에 용해된 2.5 M 노말-부틸리튬 용액(2.4 mL, 6 mmol)을 천천히 가하고 하룻밤 동안 교반하였다. 진공 건조하여 용매를 제거한 후 무수 테트라하이드로퓨란(20 mL)에 용해된 무수 ZnBr2(1.67 g, 7.4 mmol) 용액을 가하였다. 한 시간 동안 교반한 후 2-브로모벤즈알데하이드(0.92 g, 5 mmol), Pd(dba)2(29 mg, 0.05 mmol), SPhos(41 mg, 0.1 mmol)를 가하고 4시간 동안 환류시켰다. 반응 혼합액을 상온으로 냉각시키고 증류수(100 mL)를 가하여 반응을 종결시켰다. 초산 에틸(150 mL x 3회)로 추출하고 유기층을 모아 증발한 후 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 4:1)로 정제하여 5'-tert-부틸-3'-(9H-카바졸-9-일)-2'-메톡시바이페닐-2-카브알데하이드를 얻었다. 수율 1.05 g(49%).After dissolving 9-(5-tert-butyl-2-methoxyphenyl)-9 H -carbazole (1.64 g, 4.97 mmol) prepared in step (a) with anhydrous diethyl ether (15 mL), argon Under an atmosphere, a 2.5 M normal-butyllithium solution (2.4 mL, 6 mmol) dissolved in normal-hexane was slowly added and stirred overnight. After drying under vacuum to remove the solvent, anhydrous ZnBr2 (1.67 g, 7.4 mmol) solution dissolved in anhydrous tetrahydrofuran (20 mL) was added. After stirring for 1 hour, 2-bromobenzaldehyde (0.92 g, 5 mmol), Pd(dba) 2 (29 mg, 0.05 mmol), and SPhos (41 mg, 0.1 mmol) were added and refluxed for 4 hours. The reaction mixture was cooled to room temperature, and distilled water (100 mL) was added to terminate the reaction. After extraction with ethyl acetate (150 mL x 3 times), the organic layers were collected and evaporated, and the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane = 4:1) to 5'-tert-butyl-3. '-(9 H -carbazole-9-yl)-2'-methoxybiphenyl-2-carbaldehyde was obtained. Yield 1.05 g (49%).
1H NMR (600 MHz, CDCl3, ppm): 1.43 (s, 9 H), 2.86 (s, 3 H), 7.33 (t, J=7.52 Hz, 4 H), 7.48 (d, J=2.48 Hz, 3 H), 7.54 - 7.58 (m, 2 H), 7.59 (d, J=2.48 Hz, 1 H), 7.71 (t, J=7.52 Hz, 1 H), 8.09 (d, J=8.16 Hz, 1 H), 8.18 (d, J=8.44 Hz, 2 H), 10.14 (s, 1 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.43 (s, 9 H), 2.86 (s, 3 H), 7.33 (t, J=7.52 Hz, 4 H), 7.48 (d, J=2.48 Hz , 3 H), 7.54-7.58 (m, 2 H), 7.59 (d, J=2.48 Hz, 1 H), 7.71 (t, J=7.52 Hz, 1 H), 8.09 (d, J=8.16 Hz, 1 H), 8.18 (d, J=8.44 Hz, 2 H), 10.14 (s, 1 H).
단계 (c): Step (c): (5'-tert-부틸-3'-(5'-tert-butyl-3'- (9(9 HH -- 카바졸Carbazole -9-일)-2'--9-Sun)-2'- 메톡시바이페닐Methoxybiphenyl -2-일)-2 days) 메탄올(5'-tert-butyl-3'-Methanol (5'-tert-butyl-3'- (9(9 HH -carbazol-9-yl)-2'-methoxybiphenyl-2-yl)methanol의 제조Preparation of -carbazol-9-yl)-2'-methoxybiphenyl-2-yl)methanol
상기 단계 (b)에서 제조한 5'-tert-부틸-3'-(9H-카바졸-9-일)-2'-메톡시바이페닐-2-카브알데하이드(1.047 g, 2.42 mmol)를 무수 테트라하이드로퓨란(50 mL)로 용해시키고 0 ℃로 냉각시킨 후 교반하며 NaBH4(0.54 g, 14.5 mmol)을 조금씩 가하였다. 같은 온도에서 메탄올(15 mL)를 천천히 가하였다. 이 후 한 0 ℃에서 1시간, 상온에서 1시간 동안 교반하였다. 진공 건조하여 용매를 제거한 후 잔류물을 증류수(100 mL) 및 디클로로메탄(100 mL x 3회)으로 추출하였다. 유기층을 모아 증발한 후 잔류물은 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 3:1)로 정제하여 (5'-tert-부틸-3'-(9H-카바졸-9-일)-2'-메톡시바이페닐-2-일)메탄올을 얻었다. 수율 843 mg(80%).5'-tert-butyl-3'-(9 H -carbazole-9-yl)-2'-methoxybiphenyl-2-carbaldehyde (1.047 g, 2.42 mmol) prepared in step (b) above Dissolved with anhydrous tetrahydrofuran (50 mL), cooled to 0° C., stirred, and NaBH 4 (0.54 g, 14.5 mmol) was added in portions. Methanol (15 mL) was added slowly at the same temperature. Thereafter, the mixture was stirred at 0°C for 1 hour and at room temperature for 1 hour. After removing the solvent by vacuum drying, the residue was extracted with distilled water (100 mL) and dichloromethane (100 mL x 3 times). After the combined organic layers evaporated The residue was purified by column chromatography (eluent: n-hexane: dichloromethane = 3: 1) to give (5'-tert- butyl -3 '- (9 H-carbazole-9- 1)-2'-methoxybiphenyl-2-yl)methanol was obtained. Yield 843 mg (80%).
1H NMR (600 MHz, CDCl3, ppm): 1.39 (s, 9 H) 1.60 (s, 1 H) 2.88 (s, 3 H) 4.56 (d, J=8.53 Hz, 1 H) 4.61 - 4.72 (m, 1 H) 7.31 - 7.39 (m, 4 H) 7.40 - 7.51 (m, 6 H) 7.54 (s, 1 H) 7.63 (d, J=8.80 Hz, 1 H) 8.18 (d, J=7.61 Hz, 2 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.39 (s, 9 H) 1.60 (s, 1 H) 2.88 (s, 3 H) 4.56 (d, J=8.53 Hz, 1 H) 4.61-4.72 ( m, 1 H) 7.31-7.39 (m, 4 H) 7.40-7.51 (m, 6 H) 7.54 (s, 1 H) 7.63 (d, J=8.80 Hz, 1 H) 8.18 (d, J=7.61 Hz , 2 H).
단계 (d): 9-(2'-Step (d): 9-(2'- 브로모메틸Bromomethyl )-5-)-5- terttert -부틸-2--Butyl-2- 메톡시바이페닐Methoxybiphenyl -3-일)-9-3-day)-9 HH -- 카바졸(9-(2'-(bromomethyl)Carbazole (9-(2'-(bromomethyl) -5-tert-butyl-2-methoxybiphenyl-3-yl)-9-5-tert-butyl-2-methoxybiphenyl-3-yl)-9 HH -carbazole)의 제조-carbazole)
상기 단계 (c)에서 제조한 (5'-tert-부틸-3'-(9H-카바졸-9-일)-2'-메톡시바이페닐-2-일)메탄올(843 mg, 1.93 mmol) 및 PPh3(560 mg, 2.13 mmol)을 무수 테트라하이드로퓨란(20 mL)로 용해시킨 후 아르곤 분위기 및 -78℃ 하에 두었다. 강하게 교반하며 N-브로모숙신이미드(380 mg, 2.13 mmol)을 조금씩 가한 후, 이 온도에서 30분 간 교반하고 상온으로 천천히 데웠다. 진공 건조하여 용매를 제거한 후 잔류물은 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 8:1)로 정제하여 9-(2'-브로모메틸)-5-tert-부틸-2-메톡시바이페닐-3-일)-9H-카바졸을 얻었다. 수율 761 mg(79%).Prepared in Step (c) (5'-tert- butyl -3 '- (9 H - carbazol-9-yl) -2'-methoxy-biphenyl-2-yl) methanol (843 mg, 1.93 mmol ) And PPh 3 (560 mg, 2.13 mmol) were dissolved with anhydrous tetrahydrofuran (20 mL) and then placed under an argon atmosphere and -78°C. After stirring vigorously, N -bromosuccinimide (380 mg, 2.13 mmol) was added little by little, followed by stirring at this temperature for 30 minutes and warming slowly to room temperature. After removing the solvent by vacuum drying, the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane = 8:1) to give 9-(2'-bromomethyl)-5-tert-butyl-2- methoxy-biphenyl-3-yl) -9 H - to give the carbazole. Yield 761 mg (79%).
1H NMR (600 MHz, CDCl3, ppm): 1.43 (s, 9 H), 2.91 (s, 3 H), 4.53 - 4.68 (m, 2 H), 7.34 (t, J=7.47 Hz, 3 H), 7.37 - 7.46 (m, 4 H), 7.47 - 7.52 (m, 2 H), 7.55 (dd, J=11.78, 2.52 Hz, 2 H), 7.58 - 7.63 (m, 1 H), 8.20 (d, J=7.70 Hz, 2 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.43 (s, 9 H), 2.91 (s, 3 H), 4.53-4.68 (m, 2 H), 7.34 (t, J=7.47 Hz, 3 H ), 7.37-7.46 (m, 4 H), 7.47-7.52 (m, 2 H), 7.55 (dd, J=11.78, 2.52 Hz, 2 H), 7.58-7.63 (m, 1 H), 8.20 (d , J=7.70 Hz, 2 H).
단계 (e): 2,6-비스((5'-tert-부틸-3'-(9Step (e): 2,6-bis((5'-tert-butyl-3'-(9 HH -카바졸-9-일)-2'-메톡시바이페닐-2-일)메틸)피리딘(2,6-bis((5'-tert-butyl-3'-(9-Carbazole-9-yl)-2'-methoxybiphenyl-2-yl)methyl)pyridine(2,6-bis((5'-tert-butyl-3'-(9 HH -carbazol-9-yl)-2'-methoxybiphenyl-2-yl)methyl)pyridine)의 제조Preparation of -carbazol-9-yl)-2'-methoxybiphenyl-2-yl)methyl)pyridine)
상기 단계 (d)에서 제조한 9-(2'-브로모메틸)-5-tert-부틸-2-메톡시바이페닐-3-일)-9H-카바졸(671 mg, 1.35 mmol)을 무수 테트라하이드로퓨란(15 mL)으로 용해시키고 아르곤 분위기 및 -78℃ 하에 둔 후 노말-헥산에 용해된 2.5 M 노말-부틸리튬 용액(0.7 mL, 1.75 mmol)을 천천히 가하였다. 같은 온도에서 한 시간 동안 교반한 후 무수 테트라하이드로퓨란(5 mL)에 용해된 ZnBr2(450 mg, 2 mmol) 용액을 가하였다. 상온으로 천천히 데운 후 2,6-디브로모피리딘(160 mg, 0.675 mmol), Pd(dba)2(11 mg, 0.014 mmol), SPhos(11 mg, 0.027 mmol)를 가하였다. 반응 용액을 하룻밤 동안 환류시킨 후 용매를 증발시켜 제거하고 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 5:1)로 정제하여 2,6-비스((5'-tert-부틸-3'-(9H-카바졸-9-일)-2'-메톡시바이페닐-2-일)메틸)피리딘을 얻었다. 수율 540 mg(87.5%).Said step (d) a 9- (2'-bromomethyl) -5-tert- butyl-2-methoxy-biphenyl-3-yl) -9 H prepared in-carbazole (671 mg, 1.35 mmol) to After dissolving with anhydrous tetrahydrofuran (15 mL) and argon atmosphere and -78°C, a 2.5 M normal-butyllithium solution (0.7 mL, 1.75 mmol) dissolved in normal-hexane was slowly added. After stirring at the same temperature for 1 hour, a solution of ZnBr2 (450 mg, 2 mmol) dissolved in anhydrous tetrahydrofuran (5 mL) was added. After slowly warming to room temperature, 2,6-dibromopyridine (160 mg, 0.675 mmol), Pd(dba) 2 (11 mg, 0.014 mmol), and SPhos (11 mg, 0.027 mmol) were added. After the reaction solution was refluxed overnight, the solvent was removed by evaporation, and the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane 5:1) to give 2,6-bis((5'-tert-butyl) -3 '- (9 H - carbazol-9-yl) -2'-methoxy-biphenyl-2-yl) methyl) pyridine. Yield 540 mg (87.5%).
단계 (f): 화합물 1-2의 제조Step (f): Preparation of compound 1-2
상기 단계 (e)에서 제조한 2,6-비스((5'-tert-부틸-3'-(9H-카바졸-9-일)-2'-메톡시바이페닐-2-일)메틸)피리딘(540 mg, 0.59 mmol)을 무수 디클로로메탄(20 mL)으로 용해시키고 아르곤 분위기 및 -78℃ 하에 둔 후 무수 디클로로메탄(5 mL)에 용해된 BBr3(0.79 g, 3.16 mmol) 용액을 천천히 가하였다. 반응 혼합액을 상온으로 데우고 하룻밤 동안 교반한 후 증류수(50 mL)를 조심히 가하여 반응을 종결시켰다. 디클로로메탄(100 mL x 3회)으로 추출하고 유기층을 모아 증발시킨 후 잔류물을 컬럼 크로마토그래피(용리제: 노말-헥산:디클로로메탄 = 4:1)로 정제하여 화합물 1-2를 얻었다. 수율 390 mg(75%).2,6-bis((5'-tert-butyl-3'-(9 H -carbazole-9-yl)-2'-methoxybiphenyl-2-yl)methyl prepared in step (e) above )Pyridine (540 mg, 0.59 mmol) was dissolved in anhydrous dichloromethane (20 mL), placed under an argon atmosphere and -78°C, and then a solution of BBr 3 (0.79 g, 3.16 mmol) in anhydrous dichloromethane (5 mL) Apply slowly. The reaction mixture was warmed to room temperature, stirred overnight, and distilled water (50 mL) was carefully added to terminate the reaction. After extracting with dichloromethane (100 mL x 3 times), the organic layers were collected and evaporated, and the residue was purified by column chromatography (eluent: normal-hexane:dichloromethane = 4:1) to obtain compound 1-2. Yield 390 mg (75%).
1H NMR (600 MHz, CDCl3, ppm): 1.39 (s, 9 H), 1.43 (s, 9 H), 2.77 - 2.99 (m, 4 H), 4.92 (br. s., 2 H), 7.05 (t, J=8.07 Hz, 2 H), 7.23 (d, J=7.52 Hz, 2 H), 7.28 - 7.47 (m, 19 H), 7.47 - 7.55 (m, 4 H), 8.13 - 8.29 (m, 4 H). 1 H NMR (600 MHz, CDCl 3 , ppm): 1.39 (s, 9 H), 1.43 (s, 9 H), 2.77-2.99 (m, 4 H), 4.92 (br.s., 2 H), 7.05 (t, J=8.07 Hz, 2 H), 7.23 (d, J=7.52 Hz, 2 H), 7.28-7.47 (m, 19 H), 7.47-7.55 (m, 4 H), 8.13-8.29 ( m, 4 H).
실시예Example 3: 화합물 2-1의 합성 3: Synthesis of Compound 2-1
아르곤으로 치환된 100 mL Schlenk 플라스크에 상기 실시예 1에서 제조한 화합물 1-1(708 mg, 1 mmol)을 넣고 무수 톨루엔(50 mL)를 투입하여 용해시킨 후 디에틸 에테르에 용해된 3.0 M 메틸마그네슘 브로마이드 용액(1.37 mL, 4.1 mmol), 톨루엔에 용해된 1.0 M 사염화티타늄 용액(1 mL, 1 mmol)을 가하였다. 이 용액을 상온에서 하룻밤 동안 교반하였다. 진공 건조하여 용매를 제거한 후 무수 노말-헥산(50 mL)를 투입하고 10분 간 교반하며 결과물을 추출한 후 여과하였다. 여과액을 진공 건조하여 화합물 2-1을 얻었다. 수율 434 mg(55%).Compound 1-1 (708 mg, 1 mmol) prepared in Example 1 was added to a 100 mL Schlenk flask substituted with argon and dissolved by adding toluene anhydrous (50 mL), and then dissolved in diethyl ether, 3.0 M methyl Magnesium bromide solution (1.37 mL, 4.1 mmol), 1.0 M titanium tetrachloride solution (1 mL, 1 mmol) dissolved in toluene was added. The solution was stirred overnight at room temperature. After removing the solvent by vacuum drying, anhydrous normal-hexane (50 mL) was added, stirred for 10 minutes, and the resultant was extracted and filtered. The filtrate was dried under vacuum to obtain compound 2-1. Yield 434 mg (55%).
상기 실시예 3에서 합성한 화합물 2-1의 1H NMR spectrum(500 MHz, C6D6, ppm)을 도 1에 나타내었다. 1 H NMR spectrum (500 MHz, C 6 D 6 , ppm) of Compound 2-1 synthesized in Example 3 is shown in FIG. 1.
실시예Example 4: 화합물 2-2의 합성 4: Synthesis of Compound 2-2
아르곤으로 치환된 100 mL Schlenk 플라스크에 상기 실시예 2에서 제조한 화합물 1-2(886 mg, 1 mmol)를 넣고 무수 톨루엔(50 mL)를 투입하여 용해시킨 후 디에틸 에테르에 용해된 3.0 M 메틸마그네슘 브로마이드 용액(1.37 mL, 4.1 mmol), 톨루엔에 용해된 1.0 M 사염화티타늄 용액(1 mL, 1 mmol)을 가하였다. 이 용액을 상온에서 하룻밤 동안 교반하였다. 진공 건조하여 용매를 제거한 후 무수 노말-헥산(50 mL)를 투입하고 10분 간 교반하며 결과물을 추출한 후 여과하였다. 여과액을 진공 건조하여 화합물 2-2을 얻었다. 수율 127 mg(13%).In a 100 mL Schlenk flask substituted with argon, Compound 1-2 (886 mg, 1 mmol) prepared in Example 2 was added and dissolved by adding anhydrous toluene (50 mL), and then dissolved in diethyl ether, 3.0 M methyl Magnesium bromide solution (1.37 mL, 4.1 mmol), 1.0 M titanium tetrachloride solution (1 mL, 1 mmol) dissolved in toluene was added. The solution was stirred overnight at room temperature. After removing the solvent by vacuum drying, anhydrous normal-hexane (50 mL) was added, stirred for 10 minutes, and the resultant was extracted and filtered. The filtrate was dried under vacuum to obtain compound 2-2. Yield 127 mg (13%).
상기 실시예 4에서 합성한 화합물 2-2의 1H NMR spectrum(500 MHz, C6D6, ppm)을 도 2에 나타내었다. The 1 H NMR spectrum (500 MHz, C 6 D 6 , ppm) of Compound 2-2 synthesized in Example 4 is shown in FIG. 2.
실시예Example 5: 화합물 2-3의 합성 5: Synthesis of Compound 2-3
아르곤으로 치환된 100 mL Schlenk 플라스크에 화합물 상기 실시예 1에서 제조한 1-1(500 mg, 0.706 mmol)과 사염화지르코늄(165 mg, 0.706 mmol)을 넣고 무수 톨루엔(30 mL)를 투입하여 용해시킨 후 디에틸 에테르에 용해된 3.0 M 메틸마그네슘 브로마이드 용액(1.37 mL, 4.1 mmol)을 가하였다. 이 용액을 상온에서 하룻밤 동안 교반하였다. 진공 건조하여 용매를 제거한 후 무수 노말-헥산(30 mL)를 투입하고 10분 간 교반하며 결과물을 추출한 후 여과하였다. 여과액을 진공 건조하여 화합물 2-3을 얻었다. 수율 200 mg(34%).Compound 1-1 (500 mg, 0.706 mmol) and zirconium tetrachloride (165 mg, 0.706 mmol) prepared in Example 1 were added to a 100 mL Schlenk flask substituted with argon, and dissolved in anhydrous toluene (30 mL). Then a 3.0 M methylmagnesium bromide solution (1.37 mL, 4.1 mmol) dissolved in diethyl ether was added. The solution was stirred overnight at room temperature. After removing the solvent by vacuum drying, anhydrous normal-hexane (30 mL) was added, stirred for 10 minutes, and the resultant was extracted and filtered. The filtrate was dried under vacuum to obtain compound 2-3. Yield 200 mg (34%).
상기 실시예 5에서 합성한 화합물 2-3의 1H NMR spectrum(500 MHz, C6D6, ppm)을 도 3에 나타내었다. The 1 H NMR spectrum (500 MHz, C 6 D 6 , ppm) of compound 2-3 synthesized in Example 5 is shown in FIG. 3.
실시예Example 6: 화합물 2-4의 합성 6: Synthesis of Compound 2-4
아르곤으로 치환된 100 mL Schlenk 플라스크에 상기 실시예 2에서 제조한 화합물 1-2(886 mg, 1 mmol)와 사염화지르코늄(233 mg, 1 mmol)을 넣고 무수 톨루엔(30 mL)를 투입하여 용해시킨 후 디에틸 에테르에 용해된 3.0 M 메틸마그네슘 브로마이드 용액(1.37 mL, 4.1 mmol)을 가하였다. 이 용액을 상온에서 하룻밤 동안 교반하였다. 진공 건조하여 용매를 제거한 후 무수 톨루엔(50 mL)를 투입하고 10분 간 교반하며 결과물을 추출한 후 여과하였다. 여과액을 진공 건조하여 얻은 잔류물을 무수 노말-헥산 하에서 재결정하여 화합물 2-4를 얻었다. 수율 590 mg(59%).Compound 1-2 (886 mg, 1 mmol) and zirconium tetrachloride (233 mg, 1 mmol) prepared in Example 2 were added to a 100 mL Schlenk flask substituted with argon, and dissolved in anhydrous toluene (30 mL). Then a 3.0 M methylmagnesium bromide solution (1.37 mL, 4.1 mmol) dissolved in diethyl ether was added. The solution was stirred overnight at room temperature. After removing the solvent by vacuum drying, anhydrous toluene (50 mL) was added, stirred for 10 minutes, and the resultant was extracted and filtered. The residue obtained by vacuum drying the filtrate was recrystallized under anhydrous normal-hexane to obtain compound 2-4. Yield 590 mg (59%).
상기 실시예 6에서 합성한 화합물 2-4의 1H NMR spectrum(500 MHz, C6D6, ppm)을 도 4에 나타내었다. The 1 H NMR spectrum (500 MHz, C 6 D 6 , ppm) of Compound 2-4 synthesized in Example 6 is shown in FIG. 4.
실시예 7: 에틸렌/1-옥텐 공중합체의 제조Example 7: Preparation of ethylene/1-octene copolymer
약 100℃ 이하의 2L 오토클레이브 반응기에 무수 n-헥산(1 L), 1-옥텐 (230 mL), 트리이소부틸알루미늄 용액(1.0 M in n-hexane, 0.3 mL)을 가한 후, 반응기 내부 압력을 10 psi 이하가 되도록 vent하였다. 반응기의 온도를 120℃로 예열한 후 에틸렌을 500 psi로 주입하였다. 디메틸아닐리늄 테트라키스(펜타플루오로페닐) 보레이트 조촉매 용액(5 x 10-3 M in toluene, 1.5 mL)를 촉매 저장탱크에 넣은 후 고압의 아르곤 압력을 가하여 반응기에 넣고, 트리이소부틸알루미늄 화합물로 처리된 상기 실시예 3의 전이금속 화합물 촉매 용액(2 x 10-3 M in toluene, 2.5 mL)을 반응기에 넣은 후 약 30 bar의 고압 아르곤 압력을 가하여 중합 반응을 개시하였다. 중합 반응은 10분간 진행하였다. 반응열은 반응기 내부의 냉각 코일을 통해 제거하여 중합 온도를 최대한 일정하게 유지하였다. 중합 반응을 10분 간 진행한 후, 남은 가스를 빼내고 고분자 용액을 반응기의 하부로 배출시키고 과량의 에탄올을 가하여 냉각시켜 침전을 유도하였다. 얻어진 고분자를 에탄올 및 아세톤으로 각각 2 내지 3회 세척한 후, 90℃ 진공 오븐에서 12시간 이상 건조한 후 물성을 측정하였다.Anhydrous n -hexane (1 L), 1-octene (230 mL), and triisobutylaluminum solution (1.0 M in n -hexane, 0.3 mL) were added to a 2 L autoclave reactor at a temperature of about 100° C. or lower, and then the pressure inside the reactor. Vented to 10 psi or less. After preheating the temperature of the reactor to 120°C, ethylene was injected at 500 psi. Dimethylanilinium tetrakis(pentafluorophenyl) borate co-catalyst solution (5 x 10 -3 M in toluene, 1.5 mL) was placed in a catalyst storage tank, and a high pressure argon pressure was added to the reactor, and the triisobutyl aluminum compound was added. After adding the transition metal compound catalyst solution (2 x 10 -3 M in toluene, 2.5 mL) of Example 3 to the reactor, a high pressure argon pressure of about 30 bar was applied to initiate a polymerization reaction. The polymerization reaction proceeded for 10 minutes. The heat of reaction was removed through a cooling coil inside the reactor to keep the polymerization temperature as constant as possible. After the polymerization reaction was performed for 10 minutes, the remaining gas was removed, and the polymer solution was discharged to the bottom of the reactor, and excess ethanol was added to cool it to induce precipitation. The obtained polymer was washed 2-3 times with ethanol and acetone, respectively, and then dried in a vacuum oven at 90° C. for at least 12 hours, and then measured for physical properties.
실시예 8: 에틸렌/1-옥텐 공중합체의 제조Example 8: Preparation of ethylene/1-octene copolymer
상기 실시예 7에서 실시예 3에서 제조한 전이금속 화합물 대신에 실시예 4에서 제조한 전이금속 화합물을 사용하는 것을 제외하고는, 상기 실시예 7과 동일한 방법으로 에틸렌/1-옥텐 공중합체를 제조하였다. The ethylene/1-octene copolymer was prepared in the same manner as in Example 7, except that the transition metal compound prepared in Example 4 was used instead of the transition metal compound prepared in Example 3 in Example 7. Did.
실시예 9: 에틸렌/1-옥텐 공중합체의 제조Example 9: Preparation of ethylene/1-octene copolymer
상기 실시예 7에서 실시예 3에서 제조한 전이금속 화합물 대신에 실시예 5에서 제조한 전이금속 화합물을 사용하는 것을 제외하고는, 상기 실시예 7과 동일한 방법으로 에틸렌/1-옥텐 공중합체를 제조하였다. An ethylene/1-octene copolymer was prepared in the same manner as in Example 7, except that the transition metal compound prepared in Example 5 was used instead of the transition metal compound prepared in Example 3 in Example 7. Did.
실시예 10: 에틸렌/1-옥텐 공중합체의 제조Example 10: Preparation of ethylene/1-octene copolymer
상기 실시예 7에서 실시예 3에서 제조한 전이금속 화합물 대신에 실시예 6에서 제조한 전이금속 화합물을 사용하는 것을 제외하고는, 상기 실시예 7과 동일한 방법으로 에틸렌/1-옥텐 공중합체를 제조하였다. An ethylene/1-octene copolymer was prepared in the same manner as in Example 7, except that the transition metal compound prepared in Example 6 was used instead of the transition metal compound prepared in Example 3 in Example 7. Did.
실험예: 에틸렌/1-옥텐 공중합체의 물성 측정Experimental Example: Measurement of physical properties of ethylene/1-octene copolymer
상기 실시예 7 내지 10에서 제조한 에틸렌/1-옥텐 공중합체에 대해 중량, 용융온도를 측정하였다. 이때, 공중합체의 용융온도(Tm)는 TA사의 Q100을 사용하여 측정하였으며, 측정값은 중합체의 열적 이력(thermal history)을 없애기 위해 분당 10로 승온시킨 두 번째 용융(melting)을 통해 얻었다.The weight and melting temperature of the ethylene/1-octene copolymers prepared in Examples 7 to 10 were measured. At this time, the melting temperature (Tm) of the copolymer was measured using Q100 manufactured by TA, and the measured value was obtained through a second melting in which the temperature was raised to 10 per minute in order to eliminate the thermal history of the polymer.
또한, 상기 실시예 7 내지 10에서의 에틸렌/1-옥텐 공중합체 제조 시 사용된 촉매의 활성도를 측정하였다. 이때, 촉매 활성도는 제조한 공중합체 총 수득량에 대한 전이금속 화합물의 투입 몰수 및 중합 시간을 이용하여 계산되었다.In addition, the activity of the catalyst used in preparing the ethylene/1-octene copolymers in Examples 7 to 10 was measured. At this time, the catalyst activity was calculated using the number of moles of the transition metal compound and the polymerization time relative to the total yield of the copolymer.
상기 실시예 7 내지 10에 대해 상기와 같은 방법으로 물성을 측정한 후 그 결과를 하기 표 1에 나타내었다.After measuring the physical properties in the same manner as described above for Examples 7 to 10, the results are shown in Table 1 below.
(전이금속 화합물)catalyst
(Transition metal compound)
(단위: g)Polymer weight
(Unit: g)
(단위: ℃)Melt temperature
(Unit: ℃)
(단위: g·mol-1hr-1)Catalyst activity
(Unit: g·mol -1 hr -1 )
상기 표 1에 나타난 바와 같이, 본 발명에 따른 전이금속 화합물은 올리핀계 중합체를 제조하는데 있어 중합 반응 촉매로 사용될 수 있음을 확인할 수 있었다.As shown in Table 1, it was confirmed that the transition metal compound according to the present invention can be used as a polymerization reaction catalyst in preparing an oliphine-based polymer.
Claims (15)
[화학식 1]
상기 화학식 1에서,
R1 내지 R19는 각각 독립적으로, 수소; C1-20 알킬; C3-20 사이클로알킬; C2-20 알케닐; C6-20 아릴; C7-20 알킬아릴; C7-20 아릴알킬; 또는 N, O 및 S로 구성되는 군으로부터 선택되는 헤테로원자를 1개 이상 포함하는 C2-20 헤테로아릴이다.
Compound represented by the formula (1):
[Formula 1]
In Chemical Formula 1,
R 1 to R 19 are each independently hydrogen; C 1-20 alkyl; C 3-20 cycloalkyl; C 2-20 alkenyl; C 6-20 aryl; C 7-20 alkylaryl; C 7-20 arylalkyl; Or C 2-20 heteroaryl containing one or more heteroatoms selected from the group consisting of N, O and S.
R1 내지 R19는 각각 독립적으로, 수소, tert-부틸, 페닐, 또는 카바졸일인, 화합물.
According to claim 1,
R 1 to R 19 are each independently hydrogen, tert-butyl, phenyl, or carbazolyl.
R1, R3, R17 및 R19는 각각 독립적으로, tert-부틸, 페닐, 또는 카바졸일이고,
R2, R4 내지 R16 및 R18은 수소인, 화합물.
According to claim 2,
R 1 , R 3 , R 17 and R 19 are each independently tert-butyl, phenyl, or carbazolyl,
R 2 , R 4 to R 16 and R 18 are hydrogen.
R1 및 R19는 서로 동일하고,
R3 및 R17은 서로 동일한, 화합물.
According to claim 1,
R 1 and R 19 are the same as each other,
R 3 and R 17 are the same as each other, a compound.
R1 및 R19는 페닐 또는 카바졸일이고,
R3 및 R17은 tert-부틸인, 화합물.
The method of claim 4,
R 1 and R 19 are phenyl or carbazolyl,
R 3 and R 17 are tert-butyl.
R1 및 R19는 페닐 또는 9H-카바졸-9-일이고,
R3 및 R17은 tert-부틸인, 화합물.
The method of claim 5,
R 1 and R 19 are phenyl or 9H-carbazole-9-yl,
R 3 and R 17 are tert-butyl.
상기 화합물은 하기 화학식 1A로 표시되는 화합물인, 화합물:
[화학식 1A]
상기 화학식 1A에서,
R1, R3, R17 및 R19에 대한 설명은 제1항에서 정의한 바와 같다.
According to claim 1,
The compound is a compound represented by the following formula 1A, a compound:
[Formula 1A]
In Formula 1A,
The description of R 1 , R 3 , R 17 and R 19 is as defined in claim 1.
상기 화합물은 하기 화합물 1-1 또는 1-2인, 화합물:
According to claim 1,
The compound is a compound 1-1 or 1-2,
[화학식 2]
상기 화학식 2에서,
M은 4족의 전이금속이고,
L1 및 L2는 각각 독립적으로, 할로겐, C1-20 알킬; C3-20 사이클로알킬; C2-20 알케닐; C6-20 아릴; C7-20 알킬아릴; C7-20 아릴알킬; C1-20 알킬아미노; C6-20 아릴아미노; 또는 C6-20 알킬리덴이고,
R1 내지 R19는 각각 독립적으로, 수소; C1-20 알킬; C3-20 사이클로알킬; C2-20 알케닐; C6-20 아릴; C7-20 알킬아릴; C7-20 아릴알킬; 또는 N, O 및 S로 구성되는 군으로부터 선택되는 헤테로원자를 1개 이상 포함하는 C2-20 헤테로아릴이다.
Transition metal compound represented by the following formula (2):
[Formula 2]
In Chemical Formula 2,
M is a transition metal of group 4,
L 1 and L 2 are each independently halogen, C 1-20 alkyl; C 3-20 cycloalkyl; C 2-20 alkenyl; C 6-20 aryl; C 7-20 alkylaryl; C 7-20 arylalkyl; C 1-20 alkylamino; C 6-20 arylamino; Or C 6-20 alkylidene,
R 1 to R 19 are each independently hydrogen; C 1-20 alkyl; C 3-20 cycloalkyl; C 2-20 alkenyl; C 6-20 aryl; C 7-20 alkylaryl; C 7-20 arylalkyl; Or C 2-20 heteroaryl containing one or more heteroatoms selected from the group consisting of N, O and S.
M은 Ti, Zr, 또는 Hf인, 전이금속 화합물.
The method of claim 9,
M is Ti, Zr, or Hf, a transition metal compound.
L1 및 L2는 메틸인, 전이금속 화합물.
The method of claim 9,
L 1 and L 2 are methyl, a transition metal compound.
상기 전이금속 화합물은 하기 화학식 2A로 표시되는 화합물인, 전이금속 화합물:
[화학식 2A]
상기 화학식 2A에서,
M, L1, L2, R1, R3, R17 및 R19에 대한 설명은 제9항에서 정의한 바와 같다.
The method of claim 9,
The transition metal compound is a compound represented by the following formula 2A, a transition metal compound:
[Formula 2A]
In Formula 2A,
Descriptions of M, L 1 , L 2 , R 1 , R 3 , R 17 and R 19 are as defined in claim 9.
상기 전이금속 화합물은 하기 화합물 2-1 내지 2-4 중 하나인, 전이금속 화합물:
The method of claim 9,
The transition metal compound is one of the following compounds 2-1 to 2-4, a transition metal compound:
A transition metal catalyst composition comprising the transition metal compound of claim 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160107068A KR102121437B1 (en) | 2016-08-23 | 2016-08-23 | Novel ligand compound and transition metal compound comprising the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160107068A KR102121437B1 (en) | 2016-08-23 | 2016-08-23 | Novel ligand compound and transition metal compound comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180022137A KR20180022137A (en) | 2018-03-06 |
KR102121437B1 true KR102121437B1 (en) | 2020-06-10 |
Family
ID=61727087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160107068A Active KR102121437B1 (en) | 2016-08-23 | 2016-08-23 | Novel ligand compound and transition metal compound comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102121437B1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11214634B2 (en) | 2019-02-12 | 2022-01-04 | Exxonmobil Chemical Patents Inc. | Lewis base catalysts and methods thereof |
EP3924397A4 (en) * | 2019-02-12 | 2022-06-22 | ExxonMobil Chemical Patents Inc. | Lewis base catalysts and methods thereof |
US11248070B2 (en) | 2019-02-12 | 2022-02-15 | Exxonmobil Chemical Patents Inc. | Lewis base catalysts and methods thereof |
US11225539B2 (en) | 2019-02-12 | 2022-01-18 | Exxonmobil Chemical Patents Inc. | Supported transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization |
WO2020167819A1 (en) * | 2019-02-12 | 2020-08-20 | Exxonmobil Chemical Patents Inc. | Lewis base catalysts and methods thereof |
SG11202108252UA (en) * | 2019-02-12 | 2021-08-30 | Exxonmobil Chemical Patents Inc | Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization |
CN115315453B (en) * | 2020-02-11 | 2024-08-30 | 埃克森美孚化学专利公司 | Propylene copolymers obtained using transition metal bis(phenolate) catalyst complexes and homogeneous process for producing the same |
US20230287156A1 (en) * | 2020-02-11 | 2023-09-14 | Exxonmobil Chemical Patents Inc. | Polyethylene Compositions Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Homogeneous Process for Production Thereof |
KR20220152224A (en) * | 2020-02-11 | 2022-11-15 | 엑손모빌 케미칼 패턴츠 인코포레이티드 | Ethylene-alpha-olefin-diene monomer copolymer obtained using transition metal bis(phenolate) catalyst complex and method for homogeneous preparation thereof |
US20230348634A1 (en) * | 2020-02-11 | 2023-11-02 | Exxonmobil Chemical Patents Inc. | Propylene Polymers Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Homogeneous Process for Production Thereof |
US11738334B2 (en) | 2020-08-11 | 2023-08-29 | Exxonmobil Chemical Patents Inc. | Supported catalyst systems and processes for use thereof |
EP4196507B1 (en) | 2020-08-13 | 2025-05-21 | ExxonMobil Chemical Patents Inc. | Cyclic containing polymer compositions obtained using transition metal bis(phenolate) catalyst complexes and process for production thereof |
WO2022072180A1 (en) | 2020-09-30 | 2022-04-07 | Exxonmobil Chemical Patents Inc. | Bis(heterocyclic-olate) lewis base catalysts and methods thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074830A1 (en) | 2000-03-30 | 2001-10-11 | Bp Chemicals Limited | Polymerisation catalyst |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100843603B1 (en) * | 2005-12-31 | 2008-07-03 | 주식회사 엘지화학 | Transition metal compound, catalyst composition comprising the same and olefin polymerization using the same |
-
2016
- 2016-08-23 KR KR1020160107068A patent/KR102121437B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001074830A1 (en) | 2000-03-30 | 2001-10-11 | Bp Chemicals Limited | Polymerisation catalyst |
Non-Patent Citations (2)
Title |
---|
비특허1: Macromolecules(2008) |
비특허2: Archive dor pharmazle(1955) |
Also Published As
Publication number | Publication date |
---|---|
KR20180022137A (en) | 2018-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102121437B1 (en) | Novel ligand compound and transition metal compound comprising the same | |
JP6469832B2 (en) | Ligand compound, transition metal compound and catalyst composition containing the same | |
JP5972474B2 (en) | Transition metal compound, catalyst composition containing the same, and method for producing a polymer using the same | |
JP6442536B2 (en) | Ligand compound, transition metal compound and catalyst composition containing the same | |
KR102002983B1 (en) | Supported hybrid metallocene catalyst, and method for preparing polyolefin using the same | |
JP5230750B2 (en) | Nonmetallocene olefin polymerization catalyst containing tetrazole group and olefin polymerization method using the same | |
KR102189654B1 (en) | Method for preparation of novel ligand compound and transition metal compound | |
KR101184736B1 (en) | Novel transition metal compound and method for preparing olefin-based polymers | |
CN111094307B (en) | Ligand compound, transition metal compound and catalyst composition comprising the same | |
KR102558310B1 (en) | Transition metal compound, catalystic composition comprising the same, and methode for preparing polymers using the same | |
KR102022686B1 (en) | Metallocene compounds, catalyst compositions comprising the same, and method for preparing olefin polymers using the same | |
KR101705850B1 (en) | Novel ligand compound and transition metal compound comprising the same | |
KR101648137B1 (en) | Method of preparing ligand compound and transition metal compound | |
KR101229076B1 (en) | Transition metal catalysts composition and preparation method of poly-olefin using the same | |
KR102191461B1 (en) | Novel ligand compound and transition metal compound comprising the same | |
CN113039190A (en) | Transition metal compound and catalyst composition comprising the same | |
KR102128569B1 (en) | Novel transition metal compound | |
KR102034133B1 (en) | New transition metal complexes, catalysts composition containing the same, and methods for preparing ethylene homopolymers or copolymers of ethylene and α-olefins using the same | |
KR20240079012A (en) | Propylene copolymer prepared by using asymmetric dinuclear metallocene supported catalyst | |
KR102034807B1 (en) | Novel transition metal compound | |
KR20240079772A (en) | Ethylene alpha-olefin copolymer with bimodal composition, method for preparing the same, resin composition and molded artivle comprising the same | |
KR102077756B1 (en) | Method of preparing novel transition metal compound | |
KR20240078997A (en) | Polyolefin prepared by using asymmetric dinuclear metallocene supported catalyst | |
KR102029087B1 (en) | Novel transition metal compound | |
KR20240081017A (en) | Catalyst comprising transition metal for preparting polyopehin, and for preparing polyolephin using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160823 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20190219 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20160823 Comment text: Patent Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200523 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200604 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200604 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240320 Start annual number: 5 End annual number: 5 |